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Classical αβ T cells express diverse T cell antigen receptors (TCR) that recognize 
a variety of peptides presented by MHC. However, certain classes of T cells express a 
more restricted TCR that recognizes other types of antigens presented by non-classical 
MHC molecules. We sought to understand how the Natural Killer T (NKT) cell TCR is 
able to respond to a variety of lipid antigens with exquisite specificity. We also 
characterized the TCR of Mucosal-Associated Invariant T (MAIT) cells by mutagenesis. 
This allowed us to understand the structural requirements for recognition MR1:antigen 
complexes. Lastly, we undertook analyses to characterize the antigen that is recognized 
by the MAIT cell TCR. Taken together, these methods allowed us to understand how the 
semi-invariant TCRs of NKT and MAIT cells recognize their cognate antigens. 
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INTRODUCTION AND BACKGROUND1 
 
Introduction 
Life on this planet began as a single cell approximately 3.5 billion years ago. 
Since that time, organisms have been locked in a constant struggle against the threat of 
infection. Throughout the course of evolution, the development of an immune system has 
been intimately linked to an organisms’ fitness. Therefore, acquisition of a cellular 
system to prevent or treat infection was of tantamount importance to the host. Indeed, 
single-celled to multicellular organisms have a variety of cellular processes to deal with 
foreign invasion. Both the innate and the adaptive immune systems of animals today are 
the result of selective pressure to perfect defense strategies. The innate system is the first 
line of defense, containing a multitude of germline-encoded receptors for a variety of 
conserved microbial patterns. These receptors are extraordinarily conserved, as some of 
the same molecules can be found to exist in plants, bacteria and animals (1). The adaptive 
immune system, a more recent innovation, contains specialized receptors that maintain 
exquisite specificity to foreign pathogens. These highly diverse receptors are the 
signature receptors on the surface of B and T lymphocytes, the B cell receptor (BCR) and 
the T cell antigen receptor (TCR). BCRs and TCRs are generated through somatic 
rearrangements of gene segments, which recognize specific antigens derived from 
pathogens. Engagement of these receptors at the surface of lymphocytes by their specific 
                                                
1 Portions of this chapter were published in Eur. J. Immunol. (PMID 21469135).  
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antigens results in clonal division and production of cellular mediators. These 
mechanisms are the hallmark of adaptive immune response to infection. This introduction 
will address the origins of the adaptive immune system and the diversity of the T cell 
receptor.   
 
Origins of the adaptive immune system 
Around 600 million years ago, the first multicellular organisms arose in concert 
with increases in concentrations of atmospheric oxygen. This evolutionary burst of 
complex organisms over the next 100 million years fostered great opportunity for 
invading pathogens. Although we can appreciate the great complexity of the innate 
immune receptors, the need to develop a more complex system to target diverse 
pathogens soon arose. Somatic rearrangement of gene segments provide receptors that 
have the ability to recognize foreign pathogens several orders of magnitude above that of 
the innate immune system. This arm of the immune system arose somewhere around 500 
million years ago in vertebrates. The evolutionarily oldest class of the subphylum 
vertebrata, agnatha, shows the first evidence of adaptive immunity. This class contains 
the jawless fish and what remains living today is limited to several species of lamprey 
and hagfish. These precursors to jawed fish have been of particular interest to 
immunologists in order to elucidate the precise origins of what we deem the adaptive 
immune system. Experiments performed in the 1960s showed that lampreys possessed 
the ability to reject skin grafts, hinting at possible adaptive immune mechanisms (2).  
Indeed, subsequent work showed that lampreys had lymphocyte populations that 
expressed unique leucine-rich repeat sequences (LRRs) (3).  These LRRs are assembled 
3 
via copy choice mechanism in which a new DNA sequence is created by using a 
combination of several homologous templates that are located in different regions of the 
genome.(4) The LRR segments are arranged between common N- and C- terminal 
fragments and the complete sequence forms a variable lymphocyte receptor (VLR). Two 
such sets of VLRs exist, VLRA and VLRB, in separate lymphocyte lineages. Though not 
structurally related, VLRA+ lymphocytes resemble T cells and VLRB+ lymphocytes are 
able to secrete soluble forms of the receptor and therefore resemble B cells (5). Crystal 
structures of these receptors show that they are more structurally related to the innate 
Toll-like receptors, possessing a curved solenoid topology that allows for recognition of 
protein antigens (6). However, this system was soon replaced by the adaptive immune 
system of the jawed vertebrates and no semblance of the VLR system has been found in 
jawed vertebrates thus far (Figure 1-1).  
 
How did the vertebrate adaptive immune system arise? 
The development of our adaptive immune system (AIS) occurred in a relatively 
short amount of time (approximately 100 million years) (7). Prior to the emergence of B 
and T cells, agnathans relied solely on the combination of innate immunity and VLRs. 
The estimated repertoire size of the VLRs is quite large (>1014), however, it seems that an 
entirely new system came to be required. A common ancestor between jawed and jawless 
fish must have shared traits of the AIS that we know today. The process by which this 
occurred is commonly attributable to two major genetic events that occurred in this time 
period. The first of these events is whole genome duplication. A landmark proposal in 
1970 by Susumu Ohno indicated that the vertebrate genome underwent one or two rounds  
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Figure 1-1: Evolutionary conserved immunoreceptors. Three classes of 
immunoreceptors that have evolved to recognize foreign antigens. The T cell receptor 
(TCR, left panel) is present in jawed vertebrates, while the variable lymphocyte receptor 
(VLR, center panel) is expressed by the jawless vertebrates. This receptor consists of a 
series of leucine-rich repeats and is not unlike the toll-like receptors (TLR, right panel) 
that are present in invertebrates and invertebrates. Stars indicate the branch points at 





of whole genome duplication caused by the process of tetraploidization.(8) His evidence 
for such a phenonmenon was based on changes in the genome size between species at 
this time and the fact that jawed vertebrates typically have several sets of paralogous 
regions. This process could be explained by the acquisition of mutations in the extra 
copies of the genomes acquired, which eventually led to blocks of genome duplicates that 
varied to a certain degree but still maintained likeness to the original genes. 
The second process that is proposed to explain the existence of the AIS is the 
appearance of the recombination activating gene (RAG) transposon. In 1979, Sakano and 
collegues discovered the existence of recombination signal sequences surrounding the 
variable (V), diversity (D), and joining (J) segments in the T cell antigen receptor (TCR) 
locus. This gave the appearance that the TCR locus was invaded by a transposable 
element and required the activity of a recombinase in order to create a functional 
receptor. RAG1 and RAG2 genes were identified to serve this purpose. These two 
proteins recognize sequences flanking the VDJ gene segments, bring them into close 
proximity and excise lariats of intermediate gene segments. As expected RAG1/RAG2 
complexes are not found in jawless vertebrates, suggesting that their existence fostered 
the development of B and T lymphocytes. However, the interesting finding that RAG-like 
sequences can be found in sea urchins complicates this matter (9). These sequences then 
disappeared in the jawless vertebrates and reappeared in concert with TCR and BCR 
genes. A plausible explanation for this occurrence has yet to be confirmed. Nevertheless, 
the fact that both variable receptors of B and T cells have used the RAG system to 
rearrange receptors for over 500 million years with little alteration is a testament to the 
exquisite nature of our adaptive immune system.  
6 
The WGD hypothesis and emergence of MHC genes 
 One of the most fascinating examples of paralogous regions present in modern 
genomes is that of the major histocompatibility complex (MHC) groups. Classical MHC 
class I and class II molecules are polymorphic proteins that present peptide ligands 
derived from self or foreign antigens for both selection and activation of T cells. Aside 
from the classical MHC, there exists similar molecules that serve varying purposes, such 
as presentation of non-peptide ligands or stress-induced surface expression. The receptors 
for these molecules are varied as well, comprising non-classical T cells to natural killer 
(NK) cell receptors. These molecules are thought to be derived originally from two 
duplications of the MHC locus. The duplicated regions comprise 4 sets of paralogons 
encoding more than 100 gene families. This polyploidization of MHC paralogues is 
believed to have occurred en bloc between 500 and 800 million years ago. This event 
likely occurred in a common ancestor that divided the cephalochordates from the 
vertebrates (10). The regions of duplication in the human occur on chromosomes 1, 6, 9, 
and 19, with the classical polymorphic MHCI and MHCII genes located on chromosome 
6 in humans. Genomic sequencing reveals that of over 100 genes in the MHC paralogues, 
over one third are linked to immune functions (11).  
Classical MHC class I and class II genes have been observed in all jawed 
vertebrates examined, including the most evolutionarily ancient cartilaginous fish, sharks 
(12, 13). Most MHCI and MHCII-associated processing genes have been closely linked 
and conserved throughout vertebrate evolution as well. The function of these proteins are 
to present a multitude of peptides to be recognized by the T cell receptor. In this way, 
they provoke a robust immune response to foreign antigens. The conservation of the 
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MHC-TCR interaction and the central role that it plays in the adaptive immune response 
is a testament to its fundamental role in fighting infection.  
 
Classical αβ  T cells 
 The T cell receptor is on par evolutionarily with MHC, suggesting that the system 
arose together. The TCR is encoded by a diverse set of gene segments that are 
somatically rearranged to produce a heterodimeric (one α chain and one β chain) receptor 
that can recognize virtually every peptide presented by MHC. It is estimated that the gene 
segments can be rearranged to produce a repertoire of 1014 different TCRs, though this 
number is probably orders of magnitude higher than the repertoire that is actually 
expressed.(14) The locus encoding the alpha and beta chains of the TCR contains 
variable (V), diverse (D), and joining (J) segments that are randomly chosen to form the 
alpha and beta chains of the TCR. In addition to the germline configuration of the TCR, 
there can be both nucleotide removal and addition at the junctions of these gene 
segments. Taken together, this creates an enormous amount of diversity. Portions of TCR 
gene segments form three complementary determining loops (CDR1, CDR2, and CDR3) 
per chain, which are used to contact a combination of MHC and peptide. For the most 
part, there are several traditional rules that govern TCR recognition of MHC. First, the 
mostly germline-encoded CDR1 and CDR2 loops form the majority of contacts to the 
MHC itself. This is has been observed structurally in the over 30 crystallographic 
structures of TCR and MHC, which show that the TCR traditionally docks in a diagonal 
fashion. This docking mode puts the CDR1α/CDR2α over the α2/β1 helices of 
MHCI/MHCII and the CDR1β/CDR2β over the α1 helices of MHCI/MHCII. The more 
8 
diverse regions, CDR3α and CDR3β, are then poised to contact the diverse amount of 
peptides that are situated in the groove of MHC. This conformation is essential to 
understanding how the TCR recognizes antigens and how certain features of this 
macromolecular complex contribute to an effective immune response.    
 
Non-classical MHC: CD1 family 
 While the traditional system of antigen presentation by MHC is efficient for the 
recognition of protein-based antigens, many foreign antigens are probably not of protein 
nature. Until recently, such antigens were thought to be dealt with through their 
recognition by antibodies only. Seminal work by Brenner’s group in 1994 demonstrated 
that mycobacterial-derived lipids could also be recognized by some human αβ T cells 
(15). Since then, multiple studies have documented the recognition of many different 
lipids, glycolipids or even lipopeptides by T lymphocytes (16). These lipid antigens are 
presented to T cells in the context of non polymorphic MHC-like proteins of the CD1 
family that all share an antigen-binding groove unsuited to peptide binding but ideal for 
lipid interactions, as it is lined with hydrophobic residues (17). Based on sequence 
homology, the CD1 family of proteins has been classified into three groups: group 1 
contains CD1a, CD1b, and CD1c, group 2 contains CD1d, and CD1e belongs to group 3. 
Structural differences between these molecules coupled with the fact that they each have 
different trafficking patterns, makes them ideal for sampling a wide variety of foreign and 
self antigens (18).  The expression of at least one CD1 molecule has been detected in all 
mammals studied to date, but the number and composition of CD1 molecules can vary 
greatly between species. While the human genome encodes for all five of these proteins, 
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the mouse genome contains two genes encoding only for CD1d molecules and appears to 
have lost all group 1 and group 3 CD1 proteins due to a large deletion (19). As such, and 
perhaps not surprisingly, CD1d is the best characterized of these five proteins. CD1d 
reactivity defines a population of T cells known as Natural Killer T (NKT) cells (20, 21).  
CD1d has the same function in mice as is does in humans, which is to present lipids and 
glycolipids to NKT cells for selection and activation. Activated NKT cells then 
orchestrate immune responses through their rapid and diverse secretion of cytokines (22). 
Since the discovery of these cells, several groups have identified various self and foreign 
lipid antigens that when presented by CD1d, activate NKT cells. A prototypical antigen, 
alpha-galactosylceramide (αGalCer), isolated from a marine sponge, was serendipitously 
shown to activate the majority, if not all, mouse and human NKT cells (23). Taking 
advantage of this finding, another major advance in our understanding of NKT cell 
biology came with the production of CD1d tetrameric molecules loaded with αGC to 
unequivocally identify and track NKT cells ex vivo (24, 25). Unfortunately, our 
understanding of the general physiology of the T cells that recognize group 1 CD1 
molecules did not keep pace with NKT cells and has been restricted so far to the use of 
sporadically isolated T cell clones (26). The lack of group 1 CD1 tetrameric molecules 
and specific markers to identify these cells and the absence of expression of these 
molecules in mice both contributed to limit our general knowledge about group 1 CD1-
restricted T cells. However, this is likely to change soon, as group I CD1 tetramers are 




Non-classical T cells: CD1-restricted T cells 
  Group 1 CD1-reactive T cells were found in the CD4+, CD8+ and DN blood 
T cell populations in about equal proportions and were also present at comparable 
frequencies in umbilical blood. In contrast with NKT cells that express an 
effector/memory phenotype and bear a semi-invariant T cell receptor for recognition of 
CD1d molecules (20), the group-1 CD1 reactive T cells use a diverse T cell repertoire 
and are essentially naive in cord blood and progressively enriched within the memory 
compartment in adults (29).  Analysis of these cells suggest that group 1 CD1-restricted T 
cells might be primed and recruited within the effector/memory compartment during the 
lifetime of an individual. Estimation of CD1-restricted T cells suggest that they constitute 
between 1/10-1/300 of circulating T cells, a frequency comparable to MHC alloreactive T 
cells. Studies thus far have relied heavily on the autoreactive tendencies of CD1-
restricted T cells, which may lead to an underestimation of the actual frequency of group 
1 CD1-restricted T cells in human blood.  
 Although, clones reactive to all four isotypes of CD1 molecules were found, a 
predominance of T cells restricted by CD1a, followed by CD1c and CD1d (with a 
conspicuous low frequency of CD1b-restricted T cells) was detected. It is currently 
unclear why CD1b-restricted T cells were only sporadically detected by the assays used, 
as CD1b-restricted T cells have been found in PBMCs before (30). It is possible that 
CD1b-restricted T cells might be less “autoreactive” than other group 1 CD1-restricted T 
cells and/or that the transfected cell line used to stimulate the clone do not present the 
proper set of self-lipids for CD1b-restricted T cells. Using a similar approach to estimate 
the frequency of group 1 CD1-restricted T cells, a recent study also reported high 
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frequency of CD1a self-reactive T cells in the blood of healthy patients (31). Each might 
present its own set of self-lipids required to stimulate the autoreactivity of group 1-CD1-
restricted T cells clones. Together, these results suggest that the population of CD1 self-
reactive cells might have been underestimated in both studies but nevertheless represent a 
substantial part of the αβ T repertoire (Figure 1-2). 
 It is currently unclear why so many T cells directed against self-lipids are found in 
PBMCs and how their underlying autoreactivity might be regulated (31). A role for tissue 
surveillance and maintenance of homeostasis has been advanced. For example, CD1a-
restricted T cells were shown to home preferentially in the skin where in response to the 
presentation of CD1a-lipid complexes on Langerhans cells, they produce interleukin 22, 
an important component of skin defense and repair. Future studies will certainly be 
crucial in ascribing specialized roles for CD1-restricted T cells.  
 
Natural killer T cells 
While CD1d + lipid complexes can be recognized by a variety of lymphocytes 
bearing different αβ TCRs, it is also the target of a unique innate-like T lymphocyte 
population called Natural Killer T (NKT) cells. Natural killer T cells derive their name 
from the finding that these cells express a T cell receptor and usually express several 
natural killer (NK) cell receptors as well (Figure 1-3). NKT cells are subdivided into two 
classes, Type I and Type II NKT cells. These two types are classified by their TCR and 
their reactivity to the lipid antigen α-galactosylceramide (α-GalCer). Type I NKT cells, 
or iNKT cells, are reactive to α-GalCer and have a distinct TCR composition. Type II 
NKT cells do not respond to α-GalCer and have a diverse TCR repertoire. Type I NKT 







Figure 1-2: Subsets of human αβ  T cells. Subsets of αβ T cells in human PBMCs 
according to their reactivity to MHC and the MHC-like molecules, CD1 and MR1. 
Reprinted from Young and Gapin. Group 1 CD1-restricted T cells take center stage. Eur. 















Figure 1-3: Properties of NKT cells. Characteristic receptors and cytokine secretion 




somewhat of an anomaly in the world of classical αβ TCRs in that they are formed 
through the usage of a restricted set of gene segments.  The alpha chain of the NKT TCR 
is always comprised of a single canonical rearrangement between the TRAV11 and 
TRAJ18 gene segments in mice (or the orthologs genes TRAV10 and TRAJ18 in 
humans), which pairs with a limited set of Vβ segments. The NKT TCR has been shown 
to recognize a variety of self and foreign lipids presented by CD1d and its engagement at 
the surface of NKT cells leads to a rapid and diverse cytokine secretion storm. Upon TCR 
engagement, NKT cells can rapidly produce diverse cytokines such as IL-4, IFNγ, IL-10, 
IL-13, IL-17 and IL-21. As such, NKT cells have been implicated in the regulation of a 
multitude of immunological processes, including infections, cancer, and autoimmunity 
(22). 
 
Non-classical MHC: MR1 
In 1995, Hashimoto and colleagues reported the discovery of an MHC-related 
gene outside the MHC locus, but with striking similarity to classical MHC genes.(32) It 
was postulated that this finding may help explain the genetic basis of the emergence of 
MHC. Its sequence similarity was more closely related than any other nonclassical MHC 
molecule to classical MHC and it was highly conserved in distant species as well. Indeed, 
MR1 has been found in nonhuman primates, rat, bovine and ovine species. The sequence 
conservation between species is around 90% between mouse and human, as compared 
with 60-70% for other non-classical MHCs (33).  
MR1 is classified as a class Ib molecule encoded by the non-MHC linked 
monomorphic Mr1 gene (34). MR1 appears unique to mammals and is highly conserved 
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(35), suggesting that it might have evolved under strong selection pressure to fulfill a 
unique function within the immune system, possibly imposed by immune response to 
pathogens. The sequence conservation in species such as opossum and wallaby suggest 
that it may have evolved in a common ancestor of marsupial and placental mammals 
around 160-220 million years ago (36). Therefore, as with CD1d, this molecule has been 
extremely conserved alongside other antigen-presentation mechanisms.  
MR1 resembles MHCI in several respects. It contains three extracellular domains 
and covalent linkage of β2-microglobulin.  It contains a ligand-binding groove and 
concordant with MHCI studies, requires loading of an antigen for proper conformation. 
Again, similar to class I, MR1 transcript is expressed in almost every cell type examined. 
However, MR1 has been difficult to detect on the surface of cells. Therefore, 
overexpression systems were capitalized on to search for the receptor that recognized 
MR1(34). As was hypothesized, a specialized T cell receptor was found to have the 
ability to recognize the MR1 protein and the localization of cells bearing this receptor led 
to their distinction, mucosal-associated invariant T (MAIT) cells.  
 
MAIT cells 
MAIT cells are a subset of T lymphocytes that, like NKT cells, also bear a distinct 
TCR repertoire. The MAIT TCR rearrangement was first noted, alongside that of the 
NKT TCR, in analysis of double-negative TCR sequences from human peripheral blood 
(37). The preponderance of these two distinct alpha rearrangements in DN T cells 
highlighted that these repertoires seemed to be present for a distinct purpose. It was not 
until later that one of these alpha chain sequences was ascribed to the MAIT cell 
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population. The TCR alpha chain of MAIT cells is comprised of the rearrangement of 
Vα7.2-Jα33 in humans or Vα14-Jα33 in mouse. The accompanying beta chain can be 
comprised of several different gene segments, without apparent CDR3 size or amino acid 
bias. The presence of this limited repertoire expressed by MAIT cells is dependant on the 
selecting molecule MR1 (34). In the same paper it was described that these cells were 
also dependent on the presence of commensal gut bacteria and B cells, though this is 
probably contributing to their expansion and not necessarily their thymic development. 
Although these cells were first noted in the mucosa in both mice and humans, recent 
work has revealed that they are present in non-mucosal regions as well. The MAIT cell 
population has been estimated to comprise approximately 10% of peripheral blood T cells 
and up to 45% of liver T cells in humans (38). However, their presence is substantially 
smaller in mouse, which is postulated to be due to genetic restriction of common 
laboratory strains.  
Owing to the fact that germ-free animals have undetectable MAIT cells, their reactivity to 
bacterial antigens was suspected. Indeed, it was soon confirmed that MAIT cells are 
activated by various strains of bacteria and yeast (39, 40). This activation was not 
dependent on innate signals from pattern recognition receptors; instead it was shown to 
be reliant upon MAIT TCR recognition of MR1. Once activated, these cells can secrete a 
diverse set of cytokines in response, including IL-17, IFN-γ, TNF-α and IL-22(41, 42). 
Their abundant nature and rapid effector function make them an intriguing population of 
T cells that are poised to respond to both bacterial and fungal infection (Figure 1-4). As 
they are a relatively new cell population, identification of their functional role in the 








Figure 1-4: Defining features of MAIT cells. Characteristic surface receptors and 





Scope of the thesis 
An increasing number of studies have highlighted the idea that several 
populations of αβ T cells directed at non-classical MHC molecules comprise a much 
greater portion of the repertoire than was once previously thought. In this thesis, I focus 
on antigen recognition by two TCRs that belong to the non-classical T cell populations 
and are structurally conserved, the NKT TCR and the MAIT TCR. In chapter III, I 
explore the remarkable ability of the NKT TCR to recognize a variety of structurally 
similar lipid antigens with different functional outcomes. Chapter IV details the 
relationship between the MAIT TCR autoreactivity, xenoreactivity, and bacterial 
reactivity. Finally, in chapter V, I detail the biochemical characterization of the nature of 





MATERIALS AND METHODS 
 
Cell lines and mAbs 
 The mouse embryonic fibroblast LM1.8, mouse B cell line CH27, 6C2 MAIT 
hybridoma and TCRab-negative 5KC-78.3.20 hybridoma have been described 
previously(34, 43-45). All cells were maintained in complete SMEM with 10% fetal calf 
serum. Anti-MR1 mAb 26.5 has been previously described and was purified in 
house(46). 
 
TCR constructs and retroviral transduction 
All TCR constructs were produced in the same manner, as described 
previously(47). Briefly, constructs were made encoding wild-type or mutant versions of 
TCR alpha and beta chains with the surrogate markers, GFP and human nerve growth 
factor receptor (hNGFR), respectively. These plasmids were transfected into Phoenix 
retroviral packaging cell line along with the viral packaging construct pCL-ECO. This 
was achieved using Lipofectamine 2000 (Invitrogen) according to the manufacturers 
specifications. Viral supernatants were harvested and used to “spinfect” the 5KC 





Glycolipid ligand preparation 
 α-Galactosylceramide (KRN7000) was purchased from Funakoshi Ltd. All other 
glycolipids were prepared by S.A. Porcelli and A. Howell. Each glycolipid was 
resuspended in either DMSO or vehicle (25 mM Tris, 0.9% NaCl, 0.5% Tween-20). Prior 
to stimulation, lipids were heated briefly (65°, 2 min) and sonicated in a bath sonicator 
for 20 minutes. The lipids were added directly to warm medium and diluted to the 
indicated concentrations used for stimulation.   
 
Modeling of mouse MR1 
Mouse MR1 sequence (UniProt accession number Q8HWB0, 
http://www.uniprot.org/) was used to model MR1 with the homology-based web server 
Phyre(48). The crystal structure of human MR1 was used as a template and mouse MR1 
was modeled with 100% confidence(49). The molecular graphic representation was 
created with PyMol(49). 
 
Proteinase K digestion and lipid extraction 
E. coli cultures were grown overnight in Luria broth, sonicated, and the <10kD 
fraction was separated using Amicon spin columns. Ovalbumin protein (Sigma) was 
spiked into the fractions containing proteinase K (80 mg/ml), 1 mM CaCl2, 50 mM Tris 
and 10mM 2-ME. Fractions were incubated at 37°C for 24 hours. After 24 hours, the 
proteinase K activity was inhibited by adding PMSF (40 mM). α-Galactosylceramide 
(Funakoshi co, ltd, Japan) was spiked into overnight E. coli cultures and lipids were 
extracted using the method of Folch(50). Briefly, the cultures were homogenized with 2:1 
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chloroform/methanol mixture (v/v) by diluting 20 fold. Each phase was removed and 
dried separately under nitrogen (organic phase) or speedvac (interphase and aqueous). 




 5 x 104 T cell hybridomas were cultured for 20 hr with 5 x 104 the indicated APCs, 
in the presence or not of 20 mg/ml of the blocking anti-MR1 mAb (26.5) or isotype 
control. Bacterial dilutions were added to antigen presenting cells and hybridomas in 
complete media with antibiotics. Hybridoma responses were measured by an IL-2 ELISA 
using standard protocols. 
 
E. coli library screen 
 The E. coli knockout library (Keio collection) contains 3985 genetic mutants in 
duplicate (total 7970) individually plated in 96 well plates. The cultures are supplied as 
glycerol stocks and stored at -80°C. Using a pin replicator, 200 µl of fresh LB (plus 
150µg/mL kanamycin) was inoculated with each mutant. The cultures were grown 
overnight at 37°C, without shaking. The following day, 10 µl of the culture was diluted in 
300 µl of PBS and the OD600 was read on a plate reader. For the stimulation, 5 x 104  
APCs and 5 x 104  MAIT hybridomas and 10 µl of the diluted bacteria were combined in 
200 µl of media. The cells and bacteria were cultured overnight and the supernatants 
were removed the following day for IL-2 ELISA.  
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MAIT ligand preparation 
 Batches of ligand for biochemical characterization were prepared by growing 2L of 
wild type E. coli BW25113 overnight. The bacteria were spun down and resuspended in 
20 mls of 25 mM Tris pH 8 and sonicated in ice water for 20 minutes. The bacteria were 
pelleted and the supernatant was applied to a 10kD MWCO centrifugal filter device and 
the filtrate was frozen at -80°C until it was ready to use.  
 
Chromatography 
 Gel filtration chromatography was performed on a Superdex peptide column with a 
buffer containing 25 mM Tris pH 8, 2.5 mM 2-mercaptoethanol. RP-HPLC was 
performed on a C18 column with buffers containing 0.1% trifluoroacetic acid (TFA), 2.5 
mM 2-ME, and eluted with acetonitrile, 0.8% TFA, and 2.5 mM 2-ME.  
 
Mass spectrometry 
  Mass spectrometry was performed by the core facility at National Jewish Health on 
an Aligent ESI-TOF. Samples were loaded onto a C18 RP column with buffers 
containing 0.1% trifluoroacetic acid (TFA), 2.5 mM 2-ME, and eluted with acetonitrile, 
0.8% TFA, and 2.5 mM 2-ME. Results analysis was performed using qualitative analysis 






THE UNIQUE SPECIFICITY OF THE NKT T CELL RECEPTOR 
 
Introduction 
Natural killer T cells are of particular interest in therapeutic approaches owing to 
the breadth of cytokine responses they are capable of producing. Their rapid effector 
function make them poised to respond to antigen within minutes of an encounter, without 
the need for clonal expansion. Their rapid and potent cytokine response makes them 
uniquely suited for involvement in many disease states, including cancer, asthma, and 
autoimmunity (22).   
 Structural studies on the NKT TCR have shown that the TCR contacts MHC in a 
unique fashion. As opposed to traditional TCR-MHC diagonal docking modes, the NKT 
TCR sits in a parallel fashion across CD1d (Figure 3-1). In the case of the structures 
available, there are several common tendencies that occur in the TCR:lipid:CD1d 
interaction. The CDR1α loop mainly contacts the lipid antigen, while the CDR3α loop 
contacts both CD1d and the antigen. The beta chain contributes to the trimolecular 
complex through the CDR2β, which mainly contacts CD1d. It is clear that although the 
majority of contacts occur through the alpha chain of the NKT TCR, the beta chain can 
fine-tune specificity for CD1d:lipid complexes (51).  
The isolation of a lipid from the Okinawan marine sponge Agelas mauritianus has 
led to the most important tool in natural killer T cell biology. The glycolipid α-
galactosylceramide is recognized with high affinity by type I NKT cells and has been  
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Figure 3-1: Comparison of docking modes between NKT TCR and conventional 
TCR. (A, C, E) The NKT TCRα (yellow) and β (blue) in contact with human CD1d 
(green) presenting α-GalCer (magenta). (B, D, F) Classical TCR (LC13) (TCRα in 
magenta, TCRβ in cyan) in complex with HLA-B8-FLR (gray). Reprinted from Borg et 
al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 





used to identify NKT cells and explore their functional capabilities. This lipid consists of 
galactose head group attached to a ceramide tail via an α-linkage. The ceramide tail is 
composed of two long carbon chains, an 18-carbon sphingosine chain and a 26-carbon 
acyl chain. Originally this compound was shown to have potent anti-tumor effects when 
administered to mice. We now know much more about the activity of α-GalCer. 
Stimulation of NKT cells with α-GalCer results in both TH1 and TH2 cytokine 
responses; the bias for each depending on multiple factors in the context of stimulation 
(52-57). For this reason, several groups are interested in altering the components of both 
α-GalCer and other identified lipids to drive specific responses. By characterizing these 
responses, therapeutic glycolipids could be theoretically used to direct immune responses. 
 In this chapter, we examine how alterations to lipid antigens affect NKT TCR 
responses. In collaboration with the Rossjohn laboratory, we sought to examine the 
responses of one particular NKT TCR to altered glycolipid libraries through several 
methods. Their work centered on structural analyses of the NKT TCR:AGL:CD1d 
complexes and affinity measurements by surface plasmon resonance. We then extended 
these studies to understand the differences between three NKT TCRs that differ in their 
beta chains to the AGLs. This work identifies how minor alterations to both glycolipid 
structures and the TCR beta chains affect NKT T cell responses.  
 
Modified glycolipid antigens for use in vitro   
 A panel of 9 glycolipid antigens were used for the following studies on NKT TCR 
recognition (Figure 3-2). These altered glycolipid antigens differ from α-GalCer by 
length or saturation of acyl chains, length of sphinosine chains, the sugar head group, or  
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Figure 3-2: Structures of altered glycolipid ligands. (A) α-GalCer. (B) OCH. (C) α-
GalCer (C20:2). (D) α-GlcCer (C20:2). (E) 3’, 4’-deoxy-α-GalCer. (F) 4’, 4”-deoxy-α-
GalCer. (G) 4’-deoxy-α-GalCer. (H) α-GalCer (C24). (I) α-GlcCer (C24). Reprinted 
from Wun et al. A Molecular Basis for the Exquisite CD1d-Restricted Antigen 
Specificity and Functional Responses of Natural Killer T Cells. Immunity (2011) pp. 1-13 
with permission from Elsevier.  
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absence of hydroxyl groups. The 10 antigens in the AGL used for the following 
experiments are: (1) α-GalCer, (2) OCH, (3) α-GalCer (C20:2), (4) α-GlcCer, (5) 3’,4”-
deoxy-α-GalCer, (6) 4’,4”-deoxy-α-GalCer, (7) 4’-deoxy-α-GalCer, (8) 4”-deoxy-α-
GalCer, (9) α-GalCer (C24), (10) α-GlcCer. OCH is a synthetic analogue of α-GalCer 
which has truncated acyl and sphingosine chains (C24 and C9, respectively)(56). α-
GalCer (20:2) has a cis-diunsaturation in the acyl chain as compared with α-GalCer. α-
GlcCer has a glucosyl head group, but otherwise resembles α-GalCer (20:2) in the cis-
disunsaturated acyl chain. 3’,4”-deoxy-α-GalCer, 4’,4”-deoxy-α-GalCer, 4’-deoxy-α-
GalCer, and 4”-deoxy-α-GalCer are missing are missing one or hydroxyl groups from the 
α-GalCer base structure. α-GalCer (C24) contains an acyl chain that has been shortened 
from the original 26 carbons to 24 carbons. α-GlcCer (24) also has a 24-carbon acyl 
chain plus the glucosyl head group in place of the galactosyl. The difference between the 
galatosyl head group and the glucosyl head group is due to the orientation of the 4’ 
hydroxyl group. Together this collection contains alterations to both ceramide chains and 
the sugar head groups that characterize NKT cell antigens.  
 
Differential activation of the NKT TCR by altered glycolipid antigens 
 To understand how alterations to the glycolipid antigens affect NKT TCR 
activation, we cloned a prototypical NKT TCR and expressed it in a TCR-negative 
hybridoma. These cells were sorted on the basis of high expression of surface TCR and 
α-GalCer-CD1d tetramer binding ability. These cells were cultured with bone-marrow 
derived dendritic (BMDC) cells from a C57BL/6 mouse or a CD1d1d2 knockout mouse 
as a control. AGLs were added to the culture and the activiation of the NKT TCR-
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expressing hybridomas was measured by interleukin-2 (IL-2) responses over a 20-hour 
period (Figure 3-3). None of the AGLs when cultured with the CD1d1d2-/- BMDCS 
produced an IL-2 response from the NKT hybridoma (data not shown).  
 While all of the AGLs had the ability to stimulate the NKT hybridoma at the 
highest concentrations, it was at the lower concentrations that discernable differences 
could be observed. Modification of the galactose head group to eliminate either the 4’ 
hydroxyl group or conversion to glucose abrogated responses of the hybridoma to the 
AGLs. Therefore, it can be surmised that slight perturbations to the solvent exposed 
surfaces of the antigen can dramatically affect the way the TCR responds to different 
glycolipids. This effect is corroborated by additional studies combining both affinity 
measurements by surface plasmon resonance (SPR) and x-ray crystallography.   
 
Affinity measurements for altered glycolipid libraries 
 Wun and colleagues in the Rossjohn laboratory sought to measure the affinity of 
the AGL:CD1d complexes with soluble NKT TCR receptors. They used mouse CD1d 
loaded with either α-GalCer or 8 other AGLs and determined the affinity of the soluble 
Vα14i-Vβ8.2 NKT TCR for the complexes by SPR. The summarized results of this 
analysis are shown in Table 3-1. 
Based on the affinity measurements of the TCR for the antigen:CD1d complexes, 
we can draw several conclusions. The affinity measured for most of the AGL:CD1d 
complexes differed from that of the positive control α-GalCer, save for α-GalCer (C24) 
























Figure 3-3: Response of NKT TCR Vβ8.2-Jβ2.1 to AGLs. NKT TCR Vβ8.2-Jβ2.1 
used in above crystallographic and SPR studies was expressed on a T cell hybridoma and 
stimulated with C57Bl/6 BMDCs overnight plus indicated antigen in concentrations from 
left to right of 1.25e-4 µM (white bars), 1.25e-3 µM (light gray bars), 1.25e-2 µM (dark 









Table 3-1: Surface Plasmon Resonance measurement of the mouse NKT TCR to 
CD1d-α-GalCer and analogues2 
 
CD1d-glycolipids 
                               Mouse NKT TCR Vβ8.2 
Kdeq 
(nM) 







α-GalCer 59.6 5.84 0.03 19.69 54.7 3.72 
OCH 287 1.87 0.04 14.35 234 3.31 
α-GalCer (C20:2) 68.4 6.31 0.04 15.48 64.4 4.07 
α-GlcCer (C20:2) 684 4.69 0.30 2.08 645 2.22 
3ʹ′,4ʹ′ʹ′-deoxy-α-
GalCer 
174 5.99 0.11 6.00 175 2.67 
4ʹ′,4ʹ′ʹ′-deoxy-α-
GalCer 
423 3.88 0.24 2.62 617 6.37 
4ʹ′-deoxy-α-GalCer 525 4.01 0.22 2.83 556 9.31 
α-GalCer (C24) 49.3* 6.77 0.30 21.14 44.1 4.24 
α-GlcCer (C24) 554 2.40 0.20 3.47 814 6.44 
 
Kdeq derived by equilibrium fit option     
KD calc derived by kinetic fit        
t1/2= 0.693/kd 
* Kdeq estimated as response does not reach equilibrium due to slow on rate 
 
 This indicates that the length and the saturation of the acyl chains of α-GalCer do 
not have a large impact on recognition of the complexed antigen. 3’,4”-deoxy-α-GalCer 
had approximately 35% of the affinity of the α-GalCer interaction, owing to moderate 
influence of the 3’OH group on the affinity of the TCR for the antigen. The other 
antigens had KDeq values of between 0.4-0.6 µM affinity measurements, indicating a 
substantial effect on the affinity measurements by these modifications. α-GlcCer (C20:2), 
4’,4”-deoxy-α-GalCer, and 4’-deoxy-α-GalCer all exhibited around 10 fold lower 
afininty for the NKT TCR than α-GalCer. Interestingly, these results show that the NKT 
TCR has a stringent requirement for the placement of the 4’ OH on the sugar head group 
                                                
2 Compiled from published data in Wun et al. (PMID 21376639) 
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of the antigen, as these three antigens lack this residue. The 4” OH moiety did not appear 
to have as much influence as the 4’ OH placement. Overall, these data suggest that within 
this group of AGLs, there is a hierarchy of NKT TCR affinity as such: α-GalCer = α-
GalCer (C20:2) = α-GalCer (C24) > 3’,4”-deoxy-α-GalCer > OCH >  4’-deoxy-α-
GalCer = 4’,4”-deoxy-α-GalCer = α-GlcCer(C20:2) = α-GlcCer(C24). Taken together, 
this suggests that antigen discrimination by the NKT TCR can be achieved by minor 
modifications to the sugar head group of the glycolipid antigen.  
 
Structures of NKT TCRs contacting altered glycolipid libraries  
 Identification of important contact residues mediating reactivity to the different 
glycolipids is achieved most clearly through crystal structures. The Rossjohn laboratory 
crystallized the Vβ8.2-Jβ2.1 TCR in complex with 6 of the 10 glycolipids used in the 
previous experiments (Figure 3-4 and Figure 3-5). This allows for visualization of the 
CDR loops of the NKT TCR with the glycolipid antigen. Overall, the NKT TCRs 
adopted a similar binding mode in each case, with the alpha chain contributing the most 
interaction with lipid:CD1d complexes through CDR1α and CDR3α and the beta chain 
binding solely through CDR2β. Alterations to the lipid tails of the antigens only slightly 
modified the position in which the antigen was bound in CD1d, but did not affect the 







Figure 3-4: Crystal structures of mouse NKT TCR in complex with CD1d and  
AGLs. (A) α-GalCer (B) OCH (C) α-GalCer C20:2 (D) α-GlcCer (E) 3’,4”-deoxy-α-
GalCer (F) 4’,4”-deoxy-α-GalCer. TCR docking footprints colored according to CDR 
contribution: CDR1α (purple), CDR3α (yellow), CDR2β (orange). (G) Comparison of 
CD1d:OCH (yellow) with CD1d:OCH:NKT TCR trimolecular complex (light blue). α-
GalCer is shown in magenta. Reprinted from Wun et al. A Molecular Basis for the 
Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural 




Figure 3-5: Contact residues between NKT TCR CDR loops and glycolipid antigens. 
(A) (B) α-GalCer (C) (D) α-GalCer C20:2 (E) OCH (F) 3’,4”-deoxy-α-GalCer (G), 
4’,4”-deoxy-α-GalCer (H) α-GlcCer. Reprinted from Wun et al. A Molecular Basis for 
the Exquisite CD1d-Restricted Antigen Specificity and Functional Responses of Natural 





Comparison of NKT T cell receptors in stimulation 
 It has been clear that there is a hierarchy to the usage of different V beta chains in 
the NKT cell repertoire. Of the three most commonly used chains, Vβ8.2 corresponds to 
the highest affinity receptors followed by Vβ7 and Vβ2. Examination of V beta chains in 
the NKT repertoire indicates that although there are preferential Vβ chains used, there 
appears to be a substantial degreed of Jβ usage and junctional diversity. Studies 
previously in the lab have shown that there is modulation of NKT TCR responses 
corresponding to CDR3β differences (51). For our studies, we focused on the highest 
affinity group to understand how the Jβ pairing and subsequent CDR3β sequence 
modulates the response of the NKT TCR to AGLs. To address this question, we used 
three hybridomas that express the canonical NKT alpha chain paired with Vβ8.2 chains 
that each expressed a different Jβ and CDR3 sequence. The first beta chain was isolated 
from a set of NKT hybridomas made from a mouse and is deemed DN32.D3 (58). The 
second NKT V beta chain was used in the aforementioned studies in the beginning of this 
chapter (59). The third NKT beta chain is derived from the DO11.10 TCR, which 
recognizes a peptide from ovalbumin (OVA323-339) that is presented by the MHC class II 
molecules IAb and IAd(47). When this beta chain is paired with the NKT invariant alpha 
chain, it can recognize lipid antigens presented by CD1d. Each of the NKT TCRs were 
paired with the invariant alpha chain and expressed in the same TCR negative hybridoma 
(5KC-78.3.20). These hybridomas were sorted on the basis of similar expression levels of 
TCR and used in coculture experiements with the different AGLs and APCs. Table 3-2 
summarizes the beta chain differences between the three hybridomas.  
 
35 
Table 3-2: V beta sequences from NKT hybridomas 
 V beta J beta CDR3 sequence 
Vα14i - VβDN32.D3 8.2 2.4 GDPDIQNTLY 
Vα14i - Vβ8.2-Jβ2.1 8.2 2.1 GDAGGNYAEQ 
Vα14i - DOβ 8.2 1.1 GSGTTNT 
 
 In the present study, we used each of these NKT TCR-expressing hybridomas in 
co-culture experiments with CD1d-transfected A20 as the antigen-presenting cell (Figure 
3-6). It is apparent from the responses that the NKT TCR Vβ8.2-Jβ2.1 has the strongest 
response of the three NKT TCRs, followed by VβDO and finally VβDN32. The NKT 
TCRs Vβ8.2-Jβ2.1 and VβDO have a similar pattern of reactivity. They both had the 
most response to both α-GalCer (C20:2) and α-GalCer, followed by OCH, and then α-
GalCer (C24). The AGLs that had sugar head group modifications were at the lower end 
of the NKT TCRs responses. The least amount of reactivity was observed for 4’-deoxy-
α-GalCer. Overall, these data are in agreement with the previous findings for the NKT 
TCR Vβ8.2-Jβ2.1 in both the stimulatory capacity of the AGLs and the affinity 
measurements by SPR. Additionally, these studies agree with previous results from our 
lab indicating that the CDR3β loops influence reactivity to CD1d:lipid complexes (47, 
51). Therefore, both the CDR3β loops and the presence of specific functional moieties on 
the sugar head group of glycolipid antigens have substantial impact on how the NKT 







Figure 3-6: Reactivity of 3 different NKT TCRs to AGLs. NKT TCRs were expressed 
in the same T cell hybridoma and stimulated with the indicated antigen overnight with 
A20 B cells as the antigen presenting cell overnight plus indicated antigen in 
concentrations from left to right of 1.25e-4 µM (white bars), 1.25e-3 µM (light gray 
bars), 1.25e-2 µM (dark gray bars), and 1.25 e-1µM (black bars). (A) Vα14i - Vβ8.2-
Jβ2.1. (B) Vα14i - VβDN32.D3. (C) Vα14i - DOβ. Data represent the mean + s.e.m. of 




 Taken together, these data surmise that minor changes in the structure of 
glycolipid antigens can have surprisingly large affects on recognition by NKT TCRs.  
Although these TCRs are able to recognize the antigens, the changes to their structure 
translate to decreased affinity and responses. Alterations to the acyl or sphingosine tails 
do not modulate the affinity of the TCR for the complex, but they may affect the ease of 
loading of the antigen into the groove of CD1d. This in turn, decreases the reaction to the 
antigen:CD1d complexes by altering the availability for recognition. The modification 
that had the most impact on recognition was the orientation of the 4’ hydroxyl group on 
the sugar head group. This moiety is present in the unmodified galactosyl variants of the 
AGLs, but absent in the glucosyl variants. Removal of the 4’ hydroxyl in some of the 
AGLs resulted in a drastic decrease in affinity of the NKT TCR for the antigen:CD1d 
complexes. The structural analysis of this NKT TCR combined with our in vitro analysis 
of the recognition AGLs highlights the importance of certain features of glycolipid 
antigens for recognition by NKT cells. This data help to clarifiy how NKT TCRs 
recognize their cognate antigens and how we might exploit this finding in the future to 





ANTIGEN RECOGNITION PROPERTIES OF THE MAIT TCR3 
 
Introduction 
 The MAIT TCR is unique to the world of classical αβ TCRs because of its 
restricted alpha chain rearrangement. The variable region of the MAIT TCR is derived 
from the TRAV1 gene segment, the most 5’ of all of the variable alpha genes. In humans, 
it is known as Vα7.2 and in mouse, Vα19. It joins to the TRAJ33 gene segment, or Jα33. 
This rearrangement forms the canconical MAIT α chain segment and can be made from 
entirely germline-encoded residues. Modeling of this rearrangement shows that the 
canconical sequence can be formed by several different combinatorial contributions from 
the variable and joining gene segments (60). Therefore, the MAIT TCR can be made 
several different ways, without the absolute requirement for p-nucleotide addition. 
However, at the protein level, the rearrangement is always the same. This bias may be 
imposed through the course of selection in the thymus. Another intriguing characteristic 
of the MAIT TCR is its extraordinary conservation. MAIT cells have been described in 
humans, mouse, and ruminants with minimal changes to the amino acid sequence of the 
alpha chain. This implies that there is considerable pressure on the alpha chain sequence 





                                                
3 Portions of this chapter were published in PLoS ONE (PMID 23342002)  
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Table 4-1: MAIT TCRα  CDR sequences in mouse, cattle, sheep and human 
 CDR1α  CDR2α  CDR3α 
Mouse T S G F N G  Y V V L D G  R D S N Y Q L I 
Cattle T S G F N G  Y N V L D G  M D G N Y Q W I 
Sheep T S G F N G  Y N V L D G  M D G N Y R L I 
Human T S G F N G  Y N V L D G  R D S N Y Q L I 
  
Significant efforts have been underway to identify the functional purpose of 
MAIT cells. In addition to the finding that MAIT cells respond to a variety of bacterial 
and yeast species, they have been shown to have early roles in mediating clearance of 
bacterial infections. MAIT cells protect mice injected with E. coli (39), and MR1-
deficient animals have increased bacterial load after Klebsiella pneumoniae or Bacillus 
Calmette-Guérin injection compared to controls (61, 62). In humans, MAIT cells are 
found at a high-frequency in pools of M. tuberculosis-reactive T cell clones (40), and 
their number in the blood decreases in patients with active bacterial infection (39). Upon 
stimulation, mouse MAIT cells produce large amount of diverse cytokines (63), while 
sorted human MAIT cells, stimulated by anti-CD3 and -CD28 antibodies or E. coli-
infected cells, rapidly produce IFN-γ and TNF-α, as well as granzyme A and B (39, 40). 
This capacity to react rapidly to bacterial challenge provides a potential role for the 
MAIT cells in anti-microbial defense. 
 These findings have led to the idea that MAIT TCRs react with MR1 bound to a 
microbe-derived ligand. In addition, certain clones of MAIT cells detect non-infected 
MR1-expressing APCs, suggesting that, like iNKT cells (64), some MAIT TCRs might 
have a dual specificity for both microbe-derived antigen(s) as well as APC-derived, or 
media-provided, antigen(s). Two out of twenty MAIT cell hybridomas were shown to 
respond to cell lines overexpressing MR1 without exogenous antigen added to the culture 
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media (34, 65). Although all of these hybridomas express the invariant MAIT TCRa 
chain, they express different TCRβ chains, raising the possibility that each hybridoma 
might have a different antigenic specificity. Therefore, it is still unclear whether a single 
MAIT TCR can recognize both bacteria-derived antigen(s) and self-antigen(s) presented 
by MR1 or whether different subpopulations of MAIT cells are directed against different 
antigen(s). Furthermore, the contribution of the various CDRs of the mouse MAIT TCR 
to the recognition of the antigen-MR1 complex remains unknown. 
 In this chapter, we explore the unique nature of the MAIT TCR and how individual 
amino acids within the TCR contribute to the overall response. To do this, we use a 
particular MAIT TCR that responds to overexpression of MR1 on the surface of cells. 
We examine how these mutations affect the xenoreactivity of the MAIT TCR to 
understand the structural constraints imposed by evolution. We also look at how the 
amino acid sequence of the TCR responds to cells co-cultured with bacterial extracts in 
an attempt to ascertain differences in how the TCR contacts endogenous or bacterially 
derived antigens. In the last part, we examine how mutations in MR1 affect MAIT TCR 
recognition of both endogenous and bacterially derived ligands. We use the TCR and 
MR1 mutagenesis studies to compare the differences in self-recognition and bacterial 
recognition to hypothesize whether the MAIT TCR recognizes a bacterially derived 
antigen presented by MR1.  
 
The 6C2 MAIT TCR responds to overexpression of MR1 
 Studies thus far in MAIT cell biology have proved difficult due to the lack of 
suitable reagents for identifying MAIT cells in the mouse. We undertook a molecular 
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biology approach by expressing a known MAIT TCR in a hybridoma system. Orginal 
work by Tilloy and colleagues created a panel of 20 MAIT hybridomas and analyzed 
them for their TCR alpha and beta chain usage(65). These cells were then reacted against 
antigen presenting cells that had been transduced to overexpress mouse MR1 on the 
surface. Only a small percentage of these cells proved autoreactive to the overexpressed 
MR1 and that detail has allowed us to take advantage of the MAIT cells that express an 
autoreactive TCR. The TCR of one such autoreactive MAIT cell, deemed 6C2, was 
cloned and expressed in a TCR-negative hybridoma, 5KC-78.3.20. The TCR-expressing 
hybridoma produced large amounts of IL-2 (10 to 100-fold over background) when co-
cultured with LM1.8 fibroblasts transduced with a mouse MR1-encoding construct 
(Figure 4-1). However, it did not produce IL-2 when co-cultured with wildtype 
(untransduced) fibroblasts or when the beta chain was replaced with that of an NKT TCR 
(Vβ8.2-Jβ2.1). The response of 6C2 to the fibroblasts overexpressing mouse MR1 could 
be blocked by the addition of anti-MR1 (26.5), but not isotype control mAbs, thereby 
reproducing the reactivity of the original 6C2 TCR(65).  
 
Alanine-scan mutagenesis of the 6C2 MAIT TCR  
 To assess the contribution of individual amino acids in the CDRs of the 6C2 TCR, 
each residue was substituted by mutagenesis to the amino acid alanine. Several studies in 
the past have used alanine as a way to scan the T cell receptor for determine the 
contribution of particular amino acids in TCR responses to MHC:ligand complexes(66-
69). For our analysis, each mutant chain was expressed together with the appropriate 










Figure 4-1: The MAIT hybridoma response to overexpression of mouse MR1 on the 
surface of cells. Response of 6C2 MAIT hybridoma to fibroblasts overexpressing mouse 
MR1 (mMR1, light gray bars) or untransduced fibroblasts (gray bars) cocultured. MR1 
blocking antibody 26.5 (dark gray bars) or isotype control (hatched bars) was used to 
inhibit the response of the hybridoma to transduced fibroblasts. Stimulation of a 
hybridoma expressing 6C2α chain with a Vβ chain from an NKT TCR (Vβ8.2-Jβ2.1) 
with mMR1 transduced fibroblasts is shown in white bars). ELISA of IL-2 production by 
hybridoma following overnight culture with indicated APCs was determined by ELISA. 








each hybridoma was sorted for equivalent level of TCR surface expression. The sorted 
cells of each mutant were demonstrated to have equivalent responses to anti-CD3, anti-
CD28-coated plate stimulation (data not shown). Stimulation of these hybridomas using 
the LM1.8 fibroblast overexpressing mouse MR1 provided us with the pattern of 
reactivity of these mutants to the presumably self-antigen(s) expressed in fibroblast cells 
and presented by MR1 molecules or, alternatively, to ligand(s) provided by the culture 
media (Figure 4-2). Several interesting observations can be drawn from these results.  
First, the requirement for residues encoded within the invariant TCRα chain, especially 
the CDR1α loop, is much more pronounced than it is for residues within the TCRβ chain. 
Residues within the CDR1α (T26α, G28α, F29α, N30α, G31α), CDR2α (Y48α, V50α, 
L51α) and CDR3α (D92α, S93α, Y95α, I98α) loops were all necessary for the 
recognition of the self-antigen-MR1 complex. This agrees with the observation that the 
MAIT TCR alpha chain is the defining feature of the MAIT cell and has survived 
evolutionary pressure for a defined purpose. The alpha chain contributes substantially 
more energy than the beta chain, which is supported by the sequence diversity of V beta 
chains derived from murine MAIT cells.  
 Further evidence for the extraordinary evolutionary conservation of MAIT cells is 
provided by phylogenetic sequence analyses. Based on the mouse TRAV1 (used by 
MAIT cells), TRAV11 (used by iNKT cells) and TRAV19 (used by conventional T cells) 
sequences, we searched databases for orthologue genes in sixteen different species of 
placental mammals and performed a phylogenic analysis rooted to the TRAV1S1 
sequence from Oncorhynchus mykiss (Rainbow Trout) as a reference (Figure 4-3). Based 








Figure 4-2: Individual amino acid contributions from the MAIT hybridoma CDR 
loops to autoreactive response. Response of 6C2 MAIT hybridoma expressing different 
mutations of the TCR alpha chain (A, C) or TCR beta chain (B, D) to overexpression of 
mouse MR1 on LM1.8 fibroblasts (A and B) or CH27 B cells (C and D). Data represent 










Figure 4-3: Comparison of orthologous Va19-Ja33 gene segments in several species 
that express MR1. (A) Rooted phylogenic tree of TRAV1, TRAV11 and TRAV19 
orthologues from 16 different mammalian species. (B) Sequence alignment of TRAV1 
and TRAJ33 orthologues from 16 different mammalian species. 
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than TRAV11 or TRAV19. Sequence alignment showed that all the MAIT TCRα 
residues involved in the recognition of antigen-MR1 are conserved, thereby providing a 
potential explanation for the unique use of the TRAV1 and TRAJ33 gene segments by 
the MAIT TCR.  
 
Contribution of the MAIT TCRβ  chain to MR1 reactivity 
 In addition, several residues within the 6C2 Vβ chain affected the recognition of 
mouse MR1. Mutations of histidine 27 in the CDR1b loop and of Y46β in the CDR2β 
loop abolished reactivity to MR1 on fibroblasts. Interestingly, tyrosine residues at 
position 46 and 48 of the CDR2β loop of Vβ8 family gene segments have been proposed 
as important evolutionarily conserved residues for the generic recognition of MHC 
molecules(45).  Thus our results potentially extend the involvement of the Y46β residue 
to the recognition of MR1.   
 Two residues, G95β and E96β within the variable CDR3β loop appeared important 
to the recognition of a putative self antigen(s) presented by MR1 transfected fibroblasts. 
Although the glycine residue is unlikely to represent a direct contact residue, its 
flexibility might allow for the CDR3b loop to adopt the “right” configuration necessary 
for recognition, suggesting the possibility that different MAIT TCRs might use such 
flexibility to fine-tune their antigen specificities.  
 Overall, the majority of residues important for recognition of self-MR1 in the 
MAIT TCR are concentrated in the TCRα chain, however, the TCRβ chain contributes a 
significant portion of these residues as well.  This supports the idea that the degree of 
conservation of the MAIT TCRα chain is important for reactivity to MR1 and the usage 
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of several different TCRβ chains might allow for more flexibility. These results are in 
agreement with a recent study that identified the energetically important residues for the 
recognition of MR1 by the human MAIT TCR with the exception that no residue within 
the human Vβ chain was found essential in mediating MR1-restricted activation of the 
human MAIT TCR (70). 
 
MAIT TCR mutations reveal a similar pattern of reactivity to MR1-transfected B cells 
 The ubiquitous expression of MR1 transcripts suggests that several cell types might 
be able to present antigens to MAIT cells. However, it remains unclear whether MR1 
might be presenting antigen(s) common to all APCs or whether different APCs might 
each express a unique set of antigen(s). In support of the latter possibility, B cells are 
uniquely required for the expansion of MAIT cells in the periphery (34, 38).  
 We compared the reactivity of each of our MAIT TCR mutants with the LM1.8 
fibroblast and the CH27 B cells, which overexpress MR1 on their surface (Figure 4-2). 
The pattern of responses of the hybridoma collection to B cells was similar to that 
obtained with fibroblasts (Figure 4-2 C & D) Minor differences between the two APC 
types were noticed for residues V49β, D51β and E96β, but they probably reflect the 
stimulatory effectiveness of each APC than actual differences in MR1 recognition.  
 Thus, the self antigen(s) presented by MR1 expressed on fibroblast and B cells 
appear to be similar in their ability to engage a MAIT TCR. Two explanations may be 
derived from this observation. First, the ligand present by MR1 may be a conserved 
feature of both antigen presenting cells or structurally similar enough to result in the same 
pattern of reactively. Alternatively, both cells present an antigen that is derived from the 
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common element between them, the culture medium. The latter hypothesis will be further 
detailed in chapter V.  
 
MAIT TCR mutants show a similar pattern of reactivity to MR1 from different species 
 Evidence supporting evolutionary conservation of receptor-ligand interactions is 
often in the form of xenoreactive capabilities. In the case of the MAIT TCR and MR1, 
studies by Huang et al. have pointed to the xenoreactivity between mouse MAIT cells 
and MR1 from different species (71). In a series of experiments, the authors showed that 
the MAIT hybridoma 6C2 could be activated by mouse, rat, and bovine MR1, but not 
human. Mutation of mouse MR1 to the corresponding amino acids in the human MR1 
revealed that the inability of human MR1 to activate mouse MAIT cells could be 
attributed to one amino acid residue on the α1 helix, L151. For our studies, we wanted to 
see if the same amino acid residues in the MAIT TCR were required for recognition of rat 
and bovine MR1, as were required for recognition of mouse MR1 (Figure 4-4). We also 
tested our panel of TCR mutants on human MR1 to see if there was a compensatory 
mutation in the TCR that would now allow for the recognition of human MR1. Again, we 
took advantage of overexpression of MR1 on the surface of fibroblasts to stimulate the 
6C2 hybridoma in an autoreactivity manner. As we expected, the mutational patterns for 
the MAIT alpha chain remained the same, regardless of if the MR1 was derived from 
mouse, rat or bovine. Interestingly, the rat MR1 was able to stimulate the MAIT 
hybridoma to a slightly better degree than the mouse MR1. The bovine MR1 stimulated 
the MAIT hybridomas to a slightly lesser degree than the mouse MR1. The human MR1 






Figure 4-4: Reactivity of 6C2 mutants with mouse, rat, bovine, and human MR1. 
6C2 alpha chain mutant response to mouse (A), rat (B), bovine (C), and human (D) MR1 
overexpressed on the surface of B cells. 6C2 beta chain mutant response to mouse (E), rat 
(F), bovine (G), and human (H) MR1 overexpressed on the surface of B cells. Data 






species-dependent effects that are of note. For recognition of mouse and bovine MR1, 
mutation of V56α resulted in decreased responsiveness, however when this mutant was 
tested with rat MR1, the IL-2 produce was slightly above the wild-type response of the 
TCR. Additionally, mutation of S99α had the most effect on the ability of the TCR to 
recognize bovine MR1, but not rat or mouse MR1. Although minor, these differences 
suggest that there may be slight differences in either MR1 or the ligand presented by 
MR1 in the system that account for the differences in requirements for these two amino 
acids.  
 The beta chain of the MAIT TCR showed more differences in the requirement for 
certain amino acids to recognize MR1 from different species. Again, the rat MR1 was 
able to stimulate the hybridoma best, followed by the mouse MR1 and the bovine MR1. 
The human MR1 was still not able to stimulate the hybridoma. In CDR1, mutation of 
H27β abrogated the response to MR1 completely.  In CDR2β, mutations of Y46β and 
Y48β to alanine resulted in loss or diminished responses to mouse, rat and bovine MR1. 
In CDR3, E96β mutation to alanine resulted in a loss of reactivite to all species of MR1. 
However, except for one residue, F97β, alanine substitution of CDR3β amino acids 
abrogated the response of the hybridoma to rat MR1. Reactivity to bovine MR1 seemed 
to also be affected by mutations to alanine in the majority of CDR2 and CDR3, but this 
could be due to the fact that overall the reactivity of the TCR is lessened by stimulation 
with bovine MR1.  
 Taken together, the xenoreactive profile of the MAIT 6C2 hybridoma suggests 
again that the alpha chain is extremely important in recognizing MR1 and the amino acid 
requirements are essentially the same regardless of the species of MR1. The beta chain 
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has considerable flexibility, which agrees with the fact that it is found to be more diverse 
in these cells, with no obvious beta chain or CDR3 bias. This could be explained by 
differences in ligands that are presented by MR1 or the need for fine-tuning of the MAIT 
TCR response, analogous to that of the NKT TCR.  
 
MAIT TCR mutants reveal a different pattern of reactivity to cells co-cultured with E. 
coli 
 Various strains of bacteria and yeast activate MAIT cells in an MR1-dependent 
manner (39, 40). These include both gram-positive and gram-negative bacteria, such as 
Salmonella typhimurium, Escherichia coli, Staphylococcus aureus, but not Listeria 
monocytogenes or Streptococcus group A members. A still unidentified antigen(s) 
common to these microbes is thought to be directly presented by MR1 to MAIT cells. 
The 6C2 hybridoma responded to MR1 transfectants but was unresponsive to 
untransfected APCs (Figure 4-5).  Addition of E. coli to the cultures induced a response 
by the hybridoma when added to the untransfected APCs, while it only minimally 
increased the autoreactive response. This response could be blocked by the addition of 
anti-MR1 mAbs to the cultures. Interestingly, the 6C2 hybridoma could be activated by a 
very low level of bacteria. This was a consistent finding using fibroblasts, B cells and 
BMDCs (data not shown). Additionally, this result was shown regardless of the type of 
antibiotic present in the culture medium (data not shown). These results demonstrate that 









Figure 4-5: Comparison of the MAIT hybridoma response to overexpression of 
MR1 and response to E. coli coculture. Response of 6C2 MAIT hybridoma to 
fibroblasts overexpressing mouse MR1 (hatched bars) or untransduced fibroblasts (gray 
bars) cocultured with E. coli at indicated MOI. MR1 blocking antibody 26.5 (20 mg/mL) 
was used to inhibit the response of the hybridoma to wild-type fibroblasts (black bars) co-
cultured with E. coli. ELISA of IL-2 production by hybridoma following overnight 
culture with indicated APCs was determined by ELISA. Data represent the mean + s.e.m. 










indirectly activating the production of a self-ligand that, when bound to MR1, engages 
the TCR and activates MAIT cells. The former idea is likely correct since previous 
studies have indicated that MAIT cell activation occurs independently of Toll-like 
receptors or other innate pathways and that MAIT cells can be activated by fixed APCs 
cultured in the presence of bacteria(39).  
 Several mutations in both the TCRα and TCRβ chains had different effects 
depending whether the response was directed against self or the bacteria-induced 
response (Figure 4-6). In the TCRα chain, alanine substitution of T26α in the CDR1α 
and Y48α, V50α, S93α and I98α  in the CDR2α and CDR3α loops affected the 
autoreactivity, but not the bacteria-induced response. In contrast, mutation of R91α in 
CDR3α had the opposite affect since it did not influence the autoreactive response but 
decreased the bacteria-induced response. For the TCRβ chain, H27β, Y46β, and G95β  
were differentially required between the autoreactive and bacteria-induced responses 
since alanine substitution of these residues resulted in loss of autoreactivity, but had no 
effect on the E. coli-induced response.  
 The differential sensitivity to TCR sequence changes of the two responses could be 
detected using either fibroblasts or B cells as APCs, although overall the response of the 
mutants to the B cells was lower (Figure 3-7 C and D). Altogether, these results suggest 
that an E. coli-derived antigen(s) is directly recognized by the MAIT TCR in a manner 
that is similar but not identical to the recognition of the self-antigen(s). It is tempting to 
speculate that different antigen(s) might be recognized in the two situations or that the 









Figure 4-6: Amino acid requirements of the MAIT hybridoma for E. coli reactivity.  
Response of 6C2 MAIT hybridoma expressing different mutations of the TCR α chain 
(A, C) or TCR β chain (B, D) to LM1.8 fibroblasts (A and B) or CH27 B cells (C and D) 










Effect of MR1 mutations on the reactivity of the 6C2 MAIT TCR 
 Next, we analyzed how 10 different mutations localized in the predicted helical 
residues of the MR1 molecule affected the response of the 6C2 hybridoma to MR1-
overexpressing APCs or its response to the E coli-derived ligand(s) (43). Two mutations 
located on the a1 helix (L65 and G68) and two mutations on the a2 helix of MR1 (A163 
and Y152) affected the autoreactivity of the 6C2 hybridoma. Only the residues L65 and 
Y152 remained essential to the reactivity of the 6C2 TCR towards the E. coli-derived 
ligand. These centrally located residues (Figure 4-7), demonstrate an extremely focused 
energetic hot spot on the MR1 molecule necessary for the recognition by the 6C2 TCR. 
Interestingly, this hot spot is located next to the Q151 residue. Such position is encoded 
by a leucine in human MR1 and was shown to be the sole reason that human MR1 fails to 
activate mouse MAIT cells(71).  
 
Summary 
 The MAIT TCR alpha chain is composed on an invariant sequence that can be 
completely germline-encoded. This particular rearrangement is exquisitely preserved in 
distantly related species, suggesting that it has a particular role in recognition of 
MR1:antigen complexes. Indeed, mutagenesis of both the MAIT TCR alpha and beta 
chain contacts places substantial importance on the majority of amino acids in the alpha 
chain and to a lesser extent, the beta chain. Importantly, this pattern of amino acid 
requirements in the MAIT TCR remains similar in experiments in which no exogenous 
antigen was added, regardless of the antigen-presenting cell. It also remains very similar 






Figure 4-7: The MAIT hybridoma response to MR1 mutants. (A) The 6C2 MAIT 
hybridoma was stimulated with mouse MR1 mutants expressed on LM1.8 fibroblasts in 
the absence (white bars) or presence of bacteria (black bars) at an MOI of 100. The IL-2 
response in both cases could be blocked with an anti-MR1 antibody (data not shown). (B) 
The effect of the MR1 mutations on both the autoreactive response and the bacterial 
response is mapped on Phyre-generated mouse MR1 model. Mutations with an effect on 
both the autoreactive and bacterial response are shown in red, while mutations that only 
affected the autoreactive response are shown in pink. The residue attributed to the 





TCR:MR1 recognition has been preserved to the point of a high degree of xenoreactivity. 
Upon addition of E. coli, this amino acid requirement pattern shifts, possibly indicating a 
difference in antigen presentation. Taken together, this data suggests that the MAIT alpha 
chain is very important in recognizing MR1:antigen complexes. The beta chain is 
involved in the recognition to a lesser degree, possibly fine-tuning the trimolecular 
complex. The data indicate that there are certain amino acids in the CDR loops of the 
MAIT TCR that are required for autoreactive response due to overexpression of MR1 on 
the surface of different APCs. While some of these amino acids are also required for 
recognition of bacterially-induced MR1 expression, several residues show a differential 
requirement. This change in recognition suggests that perhaps there is a ligand derived 
from bacteria and presented to MAIT cells, which is different than the self-derived ligand 
presented when MR1 is overexpressed on the surface of APCs. The nature of this ligand 









The most important question in MAIT cell biology concerns the type of antigen 
these cells recognize. The nature of this antigen(s) recognized is an area currently under 
intense investigation. There were many questions to be answered when attempting to 
address this subject. First, we sought to broadly characterize the nature of the antigen. It 
was attractive to speculate that the MAIT-MR1 system is uniquely preserved in several 
different species, and therefore, must have evolved an evolutionary purpose other than 
that of the classical MHC-TCR. While we were in the process of identifying the antigen 
from MAIT cells, it was published that MAIT cells were stimulated by metabolites 
derived from the vitamin riboflavin. In a series of experiments, Kjer-Nielson and 
colleagues crystallized a folic acid metabolite in the groove of MR1(49). This metabolite 
does not stimulate MAIT cells, but has a similar structure to that of several riboflavin 
metabolites that were shown in the same paper to stimulate human MAIT cells. 
Therefore, it was postulated that structural differences between the two types of 
metabolites may account for why riboflavin metabolites are able to stimulate MAIT cells, 
whereas folic acid metabolites are not. This is currently a subject of intense interest and 
                                                
4 Portions of this chapter were published in PLoS ONE (PMID 23342002) 
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some of our data agree with this finding. Throughout the chapter, I will discuss our data 
in comparison with the work from Kjer-Nielson and colleagues.  
In this chapter, we go through several experiments designed to isolate and 
characterize the ligand from both E. coli and from the self-reactivity experiments 
performed previously. First, we wanted to identify the approximate size of the 
stimulatory antigen from E. coli. Then, we tried to broadly classify the MAIT antigen 
derived from E. coli. To address this, we performed simple digestions of E. coli fractions 
and looked for loss of stimulatory capacity. We took a genetic screening approach to 
identify the ligand through a set of E. coli knockout strains. At the same time, we sought 
to separate the antigenic activity to identify the ligand by mass spectrometry. This data in 
combination with the genetic screen pointed toward components of an essential 
biological process in E. coli. Additionally, we examined the source of the self-ligand in 
our previous autoreactive responses that occur when MR1 is overexpressed in several cell 
lines. These results further corroborated our findings by mass spectrometry.   
 
The stimulatory component of E. coli is under 10 kDaltons and sensitive to degradation 
 In order to identify the stimulatory component of E. coli, we undertook several 
experiments to characterize the nature of compound. We found that the ability of E. coli 
to stimulate cells was resistant to heat inactivation (65°), sonication and filtration (0.22 
µm). Taken together, this indicated that there was no requirement for live bacteria (data 
not shown). Interestingly, we found that sonication of the bacteria induced more IL-2 
response from the MAIT hybridoma at the same MOI as the intact bacteria. We exploited 
this finding to help increase the amount of starting material for analysis. Upon sonication 
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of the bacteria, we subjected it to a series of centrifugal molecular weight cutoff 
(MWCO) filters. We found that the stimulatory component was present in the 
flowthrough of a 10 kilodalton MWCO filter. This proved to be a finding that we could 
use to help further isolate the antigen. Another detail we noted was the apparent 
instability of the antigen in solution at varying temperatures. Preparations of the 
sonicated <10kD extracts of the antigen at 37°C would rapidly lose stimulatory capacity 
unless they contained reducing agents such as 2-mercaptoethanol (2ME), dithiothreitol 
(DTT), or tris(2-carboxyethyl)phosphine (TCEP) (Figure 5-1 and data not shown). 
Additionally, if the solutions were stored in nitrogen gas, they were also protected from 
degradation. This meant that the antigen was sensitive to oxygen-mediated degradation. 
This finding led to the use of reducing agents whenever possible to maintain antigenic 
stability while undergoing characterization experiments.  
  
The E. coli-derived MAIT antigen is resistant to proteinase K digestion and lipid 
extraction 
 In order to broadly classify the MAIT antigen, we undertook a series of 
experiments designed to place the antigen in one of three categories: protein, lipid, or 
nucleic acid. Previous experiments have suggested that it was sensitive to protease 
digestion (40). Owing a degree of similarity to NKT cells, lipids have also been proposed 
as MAIT cell antigens (72). However, in our hands the glycolipid proposed to stimulate 
MAIT cells was never able to stimulate our MAIT hybridoma (data not shown).  
 A <10 kD fraction isolated from E. coli contains the activity that stimulates the 6C2 











Figure 5-1: Stability of the antigen derived from E. coli. <10kD sonicates from E. coli 
were incubated overnight at 4° (closed circles) or 37° (open circles) with varying 
concentrations of 2ME (A) or DTT (B). Fractions were then added to cultures of the 6C2 
MAIT hybridoma and untransduced fibroblasts for overnight stimulation. IL-2 from the 








DN32.D3 hybridoma (data not shown). To control for our experiments, we independently 
spiked the fraction with either the peptide derived from ovalbumin (OVAp323-339) or α-
GalCer. This would allow us to gauge how effectively the peptide or lipid in the mixture 
of E. coli sonicates was affected by the experimental treatment.   
 The fraction was further treated, or not, with proteinase K and used to individually 
stimulate the DO11.10 or the MAIT 6C2 hybridoma (Figure 5-2). Proteinase K was 
chosen as a broad-spectrum protease, as it cleaves the peptide bonds between amino 
acids. Proteinase K treatment of the OVA-spiked fraction completely abrogated the 
response of the DO11.10 hybridoma, while the stimulation of the 6C2 hybridoma was 
unaffected.  
 Additionally, lipids were extracted from the E. coli sonicates using the Folch 
method to separate polar from non-polar compounds (50). The organic, interphase and 
aqueous phases were isolated, dried and resuspended in complete media. Each phase was 
then used to stimulate the 6C2 or DN32.D3 hybridomas. As expected, αGalCer activity 
was found within the organic and interphases but was absent from the aqueous phase. In 
sharp contrast, only the aqueous phase contained the stimulatory activity for the MAIT 
6C2 hybridoma. Altogether, these data show that the MAIT ligand is rather hydrophilic, 
but is resistant to proteinase K digestion. These characteristics contrast with the nature of 
most of the currently known antigens presented to T cells (i.e. peptides by conventional 
MHC class I and II, formylated-peptides by H2-M3, phospholipids, glycolipids and 
lipopeptides by members of the CD1 family), and argue that MAIT cells might be 









Figure 5-2: The MAIT ligand is resistant to digestion with proteinase K and is not 
part of the lipid component of <10kD E. coli culture. The <10kD fraction E. coli lysate 
was spiked with OVA protein and left untreated (solid line) or digested overnight with 
proteinase K (dashed line). MAIT ligand activity was tested with LM1.8 fibroblasts and 
the 6C2 hybridoma (A) while OVA antigenic activity was tested with A20 cells and the 
DO11.10 hybridoma (B). An overnight culture of E. coli was spun down, resuspended in 
chloroform/methanol, spiked with a-GalCer, sonicated and subjected to lipid extraction. 
Aqueous (triangles), interphase (circles), and organic (squares) phases were dried out and 
resuspended in complete media. MAIT ligand activity was assessed with the 6C2 
hybridoma and LM1.8 fibroblasts at indicated dilutions (C) while a-GalCer activity was 
detected using the DN32.D3 hybridoma and mCD1d-transfected A20 cells at indicated 




The ligand is likely to be derived from an essential pathway 
 Using the observation that MAIT cells respond to an E. coli-derived molecule, we 
chose to examine a panel of genetic knockouts to see if we could uncover the nature of 
this antigen. We utilized a ready-available E. coli knockout library deemed the Keio 
collection (73). This library contains single deletions of every nonessential gene in an E. 
coli K-12 strain BW25113. The deletions were made by targeted insertion of a kanamycin 
resistance gene. In total, there are 3985 mutations. Each of these mutations are in 
duplicate, making for a total of 7970 samples. The 96-well screening format of the library 
made it easy to inoculate overnight cultures for testing. To control for differing growth 
rate as a result of the mutations, we took and OD600 reading of the cultures following 
overnight incubation to correct for the number of bacteria. Each of these mutants was 
subjected to a stimulation assay to observe the effect of the mutation on the stimulatory 
capacity with the MAIT hybridoma (Figure 5-3). The OD600 of the cultures after growth 
was adjusted to the IL-2 output in the stimulation by using the following equation: 
 
Equation 5-1: Normalization of E. coli mutant screen data 
(OD405well/OD405average)/(OD600well /OD600well)=arbitrary values 
 
 We then plotted the arbitrary values for each mutant and chose a cutoff of the 
average of all the values + 1.5*standard deviation of the values. This allowed us to 
investigate the possible hits that fell below the average – 1.5*standard deviation. Because 
each of the mutants were plated in duplicate (i.e. mutant duplicates are found in plate 1 












Figure 5-3: Stimulatory capacity of E. coli mutants in the Keio Collection. Individual 
mutants in the Keio collection were used to stimulate the 6C2 MAIT hybridoma 
overnight and IL-2 was measured from the culture supernatant the following day. Results 
are shown as a function of arbitrary units calculated from equation 5-1, which normalizes 
IL-2 response to the bacterial culture confluency (OD600). Mutants were tested in groups 
of 18 96-well plates on five different days (corresponding to the different colors). The 










duplicates fell outside the cutoff values that we established.  
 We had hoped to find one or more mutations in the library that had completely 
abolished the stimulatory capacity of the bacteria. However, this was not the case. We did 
find some interesting mutations that were worth exploring further. The complete 
abrogation of the response could be due one of two possibilities. First, the antigen may be 
required for some essential function and therefore the knockout was not viable. 
Alternatively, there may be several antigens, in which case removal of one antigen may 
not cause a difference in the stimulatory capacity of all of the antigens. Examination of 
all 90 plates revealed 13 mutants, with duplicates, that resulted in lower stimulatory 
capacity of the MAIT hybridoma. A surprising proportion of these mutants were involved 
in the structural integrity of the inner and outer membranes. We hypothesized that these 
mutants led to compromised structural integrity and therefore the antigen was allowed to 
leak out into the bacterial cultures. However, this proved to be a difficult hypothesis to 
test. In an effort to address this, we individually cultured mutants that had a decreased 
stimulatory value in our MAIT hybridoma stimulation. However, individual cultures of 
these mutants did not reveal a decrease in their ability to stimulate the MAIT hybridoma 
at different MOIs compared to the wild-type bacteria (data not shown). Therefore, we 
chose to focus on isolation and characterization of the antigen by biochemical 






Biochemical characterization of the E. coli-derived antigen 
 In parallel to our genetic screens, we sought to resolve the complex mixture of E. 
coli sonicates by chromatographic techniques. Purified fractions could then be 
characterized by mass spectrometry. We undertook a variety of different 
chromatographic mediums to achieve separation of highly complex mixtures of E. coli 
sonicates. We found ultimately that size alone did not purify the antigen enough to 
identify it definitively. We then tried to separate the antigen based on charge, using ion 
exchange columns. In all of our experiments, the antigen did not bind to the ion exchange 
columns unless it had been modified in a way to apply a charge. Previous experiments 
had suggested that the antigen contained a thiol group that was responsible for the 
oxygen-mediated degradation. Working from this assumption, we sought to modify the 
antigen by using thiol-specific reagents. First, we used 5,5'-dithiobis-(2-nitrobenzoic 
acid) (also known as DTNB or Ellman’s reagent). This reagent specifically modifies thiol 
residues and attaches one half of the reagent. This addition is negatively charged. Using 
this finding, we treated the sonicates with DTNB and then applied them to a cation 
exchange column. We recovered the fractions from this column and used them in our 
stimulation assay to determine where the activity was present. The application of DTNB 
is reversible with other thiol-containing reagents, such as 2-ME, which is present in our 
cell culture medium at low concentrations. We found that the application of DTNB 
resulted in a shift in the fractions containing the stimulatory activity (data not shown). 
Unfortunately, we were unable to identify any known compounds from E. coli by mass 
spectrometry in these fractions. However, this lead us to use a slightly different method to 
modify the antigen. Next, we used a reagent that catalyzes the attachment of biotin to 
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thiol-containing compounds. We added this reagent to the <10kD sonicates of E. coli and 
then applied the mixture to a RP-HPLC column (Figure 5-4). Compared to the 
unmodified version of the E. coli compounds, the biotinylated antigen was captured in a 
different fraction. This fraction was analyzed by mass spectrometry for compounds that 
contained the biotin linkage. After subtraction of the biotin linkage, we identified the 
compound s-succinyldihydrolipoamide. This compound is a component of the TCA cycle 
in several different species and warranted further investigation.  
 The citric acid cycle, also known as the TCA cycle or Kreb’s cycle, arose early in 
evolution to breakdown complex energy stores into useable forms to complete essential 
cellular processes. This process provides the majority of the cell’s energy through the 
production of the cofactors nicotinamide adenine dinucleotide (NAD+) and flavin 
adenine dinucleotide (FAD+), which later go through the electron transport chain to 
produce ATP. During the TCA cycle, branched amino acids enter and are broken down 
into several intermediates.  These intermediates shuttle through the cycle, catalyzing the 
transfer of electrons to form NAD+ and FAD+. Two important dehydrogenase complexes 
that are structurally similar are present in this cycle. The pyruvate dehydrogenase 
complex (PDH) complex catalyzes the conversion of pyruvate into acetyl co-enzyme A 
(acetyl-CoA). The oxoglutarate dehydrogenase complex (OGDC) converts oxoglutarate 
(or α-ketoglutarate) into succinyl-CoA. These complexes are each composed of three 













Figure 5-4: HPLC of E. coli sonicates. <10kD E. coli sonicates were left untreated 
(gray bars) or treated with 1 mM HPDP-biotin (black bars) and applied to a RP-HPLC 
column. Fractions were collected, dried down and resuspended for use in MAIT 










Table 5-1: Subunits of the TCA cycle dehydrogenase complexes 
Complex  Subunit Name E. coli gene  Cofactor 
PDHC 






















 These complexes are decorated with multiple copies of a lipoyl domain, which 
binds to acetate (PDHC) or succinate (OGDC). The lipoyl domain consists of an 8 carbon 
chain, C6 and C8 being bound to sulfur atoms which themselves form a disulfide bond in 
the oxidized state. Through a “swinging-arm” mechanism, the lipoyl domain is reduced 
to be able to bind either an acetyl group (derived from pyruvate) or succinyl group 
(derived from oxoglutarate) through the thiol group. This complex then transfers the 
acetyl group or the succinyl group from the lipoyl domain to CoA, producing acetyl-CoA 
and succinyl-CoA. These cofactors then continue through the TCA cycle. The lipoyl 
domain is subsequently reduced to the disulfide, closed-ring complex and the process can 
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begin again.  
 The compound identified in the mass spectrometry analysis, s-
succinyldihydrolipoamide, is the intermediate species in the OGD complex formed when 
the E2-covalently-linked lipoyl domain is bound to the succinyl group derived from 
oxoglutarate. Interestingly, we found that bacteria that do not stimulate MAIT cells are 
lacking this particular complex (Table 5-2). 
 
TABLE 5-2: The presence of TCA cycle genes in different bacterial species.  
Bacterial 
species 
sucA sucB lpd sucD sucC sdhA sdhB sdhC sdhD 
E. fecalis - - + - - - - - - 
E. coli + + + + + + + + + 
K. pneumoniae + + + + + + + + + 
L. acidophilus - - - - - - - - - 
L. 
monocytogenes 
- - + - - + + + + 
M. tuberculosis - + + + + + + + + 
M. abcessus - + + + + + + + + 
P. aeruginosa + + + + + + + + + 
S. typhimurium + + + + + + + + + 
S. aureus + + + + + + + + + 
S. epidermis + + + + + + + + + 
S. pyogenes - - + - - - - - - 
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Reexamination of the E. coli knockout collection 
 The finding that antigen may be derived from a part of the citric acid cycle 
warranted another look at the library of E. coli mutants. This time, we grouped the 
mutants that, when cultured with the MAIT hybridoma, resulted in the highest amount of 
IL-2. Interestingly, most of these mutants were connected through their involvement in 
the citric acid cycle (Figure 5-5 and 5-6). We hypothesized that mutants in this pathway 
may overall contribute to excess buildup of the stimulatory activity found in the E. coli 
sonicates. Considerable efforts were made to perturb the TCA cycle, such as anaerobic 
growth conditions, alternative carbon sources, and addition of pathway intermediates 
(data not shown). However, none of these experiments were conclusive in pinpointing a 
definitive role for TCA cycle metabolites in MAIT cell activation. Future experiments 
involving the synthesis of the compound identified by mass spectrometry are planned.  
 
Uncovering the nature of the self-antigen 
 Although most of our analysis involved attempts to identify the antigen from E. 
coli, we were also interested in the ligand presented by MR1 to MAIT cells when MR1 
was overexpressed on the surface of cells. When MR1 is overexpressed on the surface of 
MR1 it contains a ligand on the surface that must be derived from the cell itself, as this 
effect occurs in absence of an exogenously added component. However, this effect is not 
seen when there are physiologic levels of MR1. We examined the medium in which the 
cells are grown for any non-animal source of potential antigens. This led us to the idea 
that vitamins are a potentially foreign source of antigen. The name vitamin is 
portmanteau of vital amines, as they were found to be essential for many biological 
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processes.5 Animals do not have the capabilities to synthesize these compounds and most 
come directly from our diet. Most plants, bacteria, and yeast are able to synthesize these 






Figure 5-5: Portion of the citric acid cycle in E. coli. E. coli gene names shown in bold 
next to the portion of the pathway in which they participate. Knockout mutants of the 
genes shown were tested for ability to stimulate the MAIT hybridoma. Mutants in blue 
resulted in an increased IL-2 response from the MAIT hybridoma above that of the wild-
type E. coli.  
 
                                                
5 Vitamins were discovered in 1912 by a Polish biochemist, Casimir Funk, who found 
that certain diseases could be attributed to nutritional deficiencies.  
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Figure 5-6: E. coli mutants that confer increased stimulatory ability to the MAIT 
hybridoma. Mutants from the Keio collection were grouped according to the highest IL-
2 produced when cocultured with the MAIT hybridoma and APCs (after normalization to 
the OD600 of the cultures). Mutants were subjected to STRING analysis (http://string-
db.org/) for known and predicted protein-protein interactions.  
 
75 
across the epithelial layer.  
 The medium designed for mammalian cell culture contains inorganic salts, amino 
acids, glucose, phenol red, and vitamin supplements. The vitamins are derived from 
biological sources, including fungi and bacteria. Therefore, they made an interesting 
candidate to test for the source of the self-antigen present in the cultures. Each vitamin 
was added to a culture of the wildtype (untransduced) fibroblasts and the MAIT 
hybridoma (Figure 5-7). Surprisingly, a solution of riboflavin (vitamin B2) stimulated the 
MAIT hybridoma at levels near the <10kD E. coli sonicates. This finding was supported 
by the use of an anti-MR1 blocking antibody to abolish the riboflavin response.  
 Riboflavin (7,8-dimethyl-10-ribityl isoalloxazine) is a water-soluble vitamin that is 
found in a variety of foods. It is mostly absorbed by enterocytes in the small intestine and 
transported through the plasma bound to albumin or other proteins. It is essential for 
many cellular processes, owing to the fact that is a precursor to the formation of two 
essential cofactors, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN). 
These cofactors participate in redox reactions, many of which are attributed to cellular 
respiration. FMN is formed by the addition of a phosphate addition to the ribityl side 
chain of riboflavin. FAD is formed by the addition of two phosphate groups and adenine 
on the ribityl side chain. Both of these cofactors are present in several dehydrogenase 
complexes, including NADH and OGDH. They participate in reactions by accepting 
electrons from the isoalloxine ring to transfer to electron acceptors.  
 Shortly after this finding, Kjer-Nielson and colleagues published data regarding the 
identification of riboflavin metabolites that have the capacity to stimulate human MAIT 








Figure 5-7: Stimulation of 6C2 MAIT hybridoma with increased concentrations of B 
vitamins. (A) B vitamins found in cell culture medium were added at indicated 
concentrations above that of the basal medium formulation to MAIT hybridoma and 
untransduced fibroblasts for overnight stimulation. (B) Riboflavin was cultured with 6C2 
MAIT hybridoma and fibroblasts (dashed line) with the addition of an anti-MR1 blocking 






the group crystallized in the groove of MR1. Each of the three riboflavin metabolites are 
nearly identical and differ from 6-FP by the ribityl side chain that is positioned off of the 
pterin ring. It is postulated that this extra moiety extends above the groove of MR1 and 
may be recognized by the TCR. Their data also shows that it is only the identified 
metabolites and not pure riboflavin that is responsible for the MAIT stimulation. 
 
Examination of the riboflavin components 
 Kjer-Nielson and colleagues findings show that they were unable to achieve 
stimulation of MAIT cells by purified riboflavin and that only the synthesized 
metabolites were able to stimulate MAIT cells. Analysis of our original riboflavin 
solution indicated that it contained 94% pure riboflavin and a mixture of metabolites and 
other biological compounds. The riboflavin that we used in our assays is isolated from 
the metabolysis of cornstarch by the fungus Ashbya gossypii. Therefore, we can assume 
that metabolites present in the mixture are indeed from a biological source.  
Of the metabolites identified by mass spectrometry, we were able to narrow our 
candidate antigens down systematically. We identified lumazine in the mixture, which is 
the major degradative product release from the photolysis of riboflavin. This finding led 
us to see if photolysis of riboflavin resulted in change in the stimulatory capacity of the 
riboflavin mixture. Indeed, exposure of a riboflavin solution to light resulted in a loss of 
over 50% of the IL-2 produced as a result of stimulation of the MAIT hybridoma (data 
not shown). This indicated to us that the photolytic degradation of the ribityl side chain 
abrogates the response of the hybridoma to riboflavin or ribityl-containing metabolites. 
The riboflavin solution contains two such metabolites that contain the ribityl side chain 
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and are likely affected by exposure to light. The riboflavin and associated metabolites are 
shown in Table 5-3.  
 
Table 5-3: Compounds identified in riboflavin solution 
Name Mass Structure 














We purchased the only commercially available compound of the two to test for 
activity. This compound also was able to stimulate the MAIT hybridoma. However this 













Figure 5-8: Stimulation of MAIT hybridoma with riboflavin and associated 
metabolites. MAIT hybridomas were incubated with riboflavin (solid line) or 7-ethyl-8-
chloro-10-(1’-D-ribityl) isoalloxazine (dashed line) at indicated concentrations overnight. 








(Figure 5-8). This result suggests two different explanations. First, the compound is of 
unknown purity and therefore, the 7-ethyl-8-chloro-10-(1'-D-ribityl) isoalloxazine 
concentration may be less than calculated. The other explanation is that another yet 
unknown metabolite may be present that is accounting for the stimulatory activity. 
Efforts are underway to analyze the compound by mass spectrometry for purity.  
   
Summary 
 The nature of the antigen presented by MR1 to MAIT cells is an area of intense 
research and will likely uncover much about the function and purpose of these cells. We 
attempted to identify the antigens presented to MAIT cells as a result of both 
autoreactivity and bacterial reactivity by several methods. First, we screened a library 
containing approximately 8,000 E. coli mutants for alterations in the MAIT cell response. 
While none of the mutants in this library completely abrogated the response, we did note 
that several related mutants were implicated in an increased response from the MAIT 
hybridoma. This coincided with two findings that related to the citric acid cycle 
metabolism in E. coli. First, we identified a component of this cycle by chromatographic 
separation of E. coli sonicates and mass spectrometry analysis. Second, we found that 
riboflavin solutions were able to stimulate the MAIT hybridoma when added to 
untransduced fibroblasts in culture.  
 The discovery that they respond to vitamin metabolites raises several questions. 
How do these cells then discriminate between harmful and beneficial bacterial strains? 
When are they exposed to riboflavin metabolites? Are these metabolites solely indicative 
of the general structure of the metabolites? Additionally, we found that the metabolites in 
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our mass spectrometry analysis are different from that of those identified by Kjer-Nielson 
and colleagues. Therefore, this topic will require further investigation. Currently, we are 
in the process of completing several experiments to address some of the questions. Our 




DISCUSSION AND FUTURE DIRECTIONS 
 
Understanding conserved rules for NKT TCR recognition of glycolipid antigens 
NKT cells are uniquely poised to fulfill a specialized role in the immune system. 
Their rapid and diverse cytokine response enables them to direct and modulate various 
immune responses. NKT cells use a TCR comprised of specific alpha chain 
rearrangement that pairs with a limited number of beta chains to contact both antigen and 
CD1d. To better understand how the NKT TCR contacts different antigens, we 
collaborated with the Rossjohn laboratory to analyze NKT TCR recognition of panel of 
glycolipid antigens. We achieved this through several methods, including cell-based 
stimulation assays, x-ray crystallography, and surface plasmon resonance. NKT cells 
have the ability to respond to a variety of different glycolipid antigens. This is surprising 
considering that their TCR repertoire diversity is compromised by their alpha chain 
restriction. Additionally, CD1d is non-polymorphic. How do NKT TCRs recognize such 
diverse glycolipids? What conserved features are contacted by the TCR to allow for such 
potent responses? How does the NKT TCR distinguish modifications to the antigen to 
potentiate the different responses? These are all questions that have intrigued the NKT 
cell field for years.  The studies outlined in chapter III sought to address these questions. 
By creating a panel of glycolipids with subtle alterations to the structure of the original 
antigen, α-galactosylceramide, we were able to understand how the presence of motifs 
within the glycolipid antigens affected functional outcomes of NKT cell responses. These 
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studies were designed to mimic those of classical αβ T cell recognition of altered peptide 
ligands, which showed that minor changes in peptides result in dramatic T cell functional 
outcomes (74). Indeed, our NKT data reflects this phenomenon as well. The NKT TCR 
used in our studies was extremely sensitive to loss of the 4’OH group on the galactose 
sugar head group. This is indicative of the fine specificity of the NKT TCR to small 
structural components of lipid antigens. Although from our data, loss of 3’OH and 4”OH 
groups did not have as great of an effect on NKT TCR recognition of AGLs. From the 
structural data, we can observe a loss of interactions with these residues, but overall they 
do not contribute as greatly to the functional outcome as the 4’OH moiety. This means 
that although NKT cells are able to recognize a broad variety of lipid antigens, they 
possess exquisite specificity to certain functional motifs present within these antigens.  
 Of course, there are several additional ways in which different antigens may 
affect NKT cell functional outcomes. First, the antigens may be preferentially loaded into 
CD1d depending on structural components of the antigen that contribute to the ease of 
loading. This may be true in the case of alterations to the acyl or sphingosine chains. For 
example, in our data, unsaturated carbons in the acyl chain did not affect the affinity 
measurements of the NKT TCR, but they did affect the proliferation and IL-2 response 
when used in cell-based assays (75). Second, the beta chain repertoires of NKT cell 
populations are diverse and this diversity may contribute to differential recognition of 
specific antigens. This was also reflected in our data, as Vβ7+ NKT cells were selectively 
proliferating in response to AGLs that did not contain the 4’OH moiety. Third, as has 
been demonstrated, some alterations to structural components of NKT antigens do not 
affect TCR recognition, but instead allow for the targeting of distinct APCs (76). In this 
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way, the context in which the antigen is presented can also result in different functional 
outcomes of activation.  
 Taken together, this data is important because α-GalCer is currently used in 
human clinical trials for the treatment of several diseases. The potency of this antigen in 
driving NKT cell responses makes it an attractive candidate for therapeutic use. 
Alternatively, modifications to α-GalCer may be of even more benefit in the future due to 
their induction of a more specific and less potent response (77). This is an area of intense 
interest in the NKT cell field, as these altered glycolipids have potential applications in a 
variety of diseases, such as cancer, asthma, and autoimmunity. 
 
Structural determinates of the MAIT TCR:MR1 interaction 
 MAIT cells, defined by their expression of the Vα19-Jα33 rearrangement, have 
been conserved in several species with little variation. MR1 has also been observed in 
distantly related species with little alteration. Phylogenetic studies have suggested that 
MAIT cells may be approximately 200 million years old and have been well conserved to 
present bacterial and yeast antigens. We sought to characterize the MAIT TCR 
recognition of MR1 so that we might understand the role that MAIT cells have in 
infection. To do this, we mutagenized the MAIT TCR and examined the impact of 
distinct amino acid residues in the recognition of MR1 that was induced in the presence 
and absence of bacteria. We also compared the requirement for these residues when MR1 
was derived from different species. Lastly, we analyzed MR1 mutants for differences in 
MAIT TCR recognition based on the presence of E. coli. These studies revealed that, as 
expected, the alpha chain of the MAIT TCR is extremely important in recognition of 
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MR1 in all cases. This is not surprising due to the semi-invariant nature of the alpha 
chain and the high degree of conservation. During the writing of this thesis, the crystal 
structure of a human MAIT TCR in complex with bovine MR1 was solved (78). This 
structure shows that the MAIT TCR docks in a diagonal fashion, similar to that of 
classical TCR:MHC interactions. Unlike NKT cells, all of the CDR loops are positioned 
directly above MR1 with CDR1α/CDR2α above MR1α2 helix, CDR1β/CDR2β above 
the MR1α1 helix and CDR3α/CDR3β over the MR1 ligand-binding groove. Electrostatic 
interaction maps from this structure support our hypothesis, showing that the major 
binding contribution comes from the alpha chain of the MAIT TCR. Although clear 
electron density exists for the ligand in this structure, it was unable to be identified. 
However, it does show similarity to the 6-FP that was identified in the MR1 structure 
from Kjer-Nielson. The authors postulate that heterogeneity of the ligand in solution may 
be responsible for the inability to identify the antigen in the groove of MR1.  
In our studies, we also noted that the pattern of amino acid requirements for the 
MAIT TCR is the same for the autoreactive response, regardless of the APC or the 
species from which MR1 is derived. This pattern shows differential requirements upon 
bacterial co-culture. This suggests that there may be a bacterially-derived antigen that is 
loaded into MR1 for recognition by the MAIT TCR. This finding led us to attempt to 
identify both the self and E. coli-derived antigens presented to the MAIT TCR.  
 
Uncovering the nature of the MAIT cell antigen 
 MAIT cells comprise a surprising large portion of the T cell repertoire, yet we 
still do not yet know what role they have in the immune system. In addition to 
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recognizing foreign pathogens, MAIT cells have been found in both brain lesions from 
multiple sclerosis patients and several types of human tumors (79, 80). MR1-/- mice were 
shown to have exacerbated disease progression in experimental autoimmune encephalitis, 
a murine model of multiple sclerosis (81).  These studies and others have suggested an 
inverse correlation between the diversity of pathogens encountered by certain populations 
and the numbers of MAIT cells as found in MS patients (82, 83). Nevertheless, we do 
know that they are capable of responding to a variety of bacterial and yeast species, but 
how they recognize such diverse pathogens is not clear. In our work, we attempted to 
understand if there was a difference in the reactivity of the MAIT TCR towards the self-
antigens or bacterial antigens. This was the first indication that they may distinguish 
between two different antigens, one derived from self and the other from bacteria. We 
took this a step further to try to identify the antigen from E. coli by both genetic and 
biochemical methods. This approaches in tandem led us to believe that there may be an 
involvement of the TCA cycle in MAIT cell activation. It is interesting to speculate that 
MAIT cells recognize a ligand derived from the TCA cycle to gauge the metabolism of 
certain pathogens. Perhaps their location in the mucosal tissue of the gut allows for quick 
response upon pathogenic breach of the epithelial layer. Conservation of ligands from the 
TCA cycle may permit such broad and diverse recognition of several species. This may 
uniquely poise MAIT cells as the first responders to invading pathogens at the interface 





Riboflavin derivatives and the E. coli-derived antigen 
 The finding that MAIT cells are responsive to vitamin metabolites is certainly 
intriguing. Vitamins are an essential part of normal cell function and many organisms 
rely on bacteria and yeast to supply them. Therefore, several commensal species have a 
symbiotic relationship with their host. How these vitamins might promote MAIT cell-
mediated immunity is still unclear. Kjer-Nielson and colleagues speculate that these 
metabolites are presented on the surface of infected cells. Curiously, MAIT cells are 
absent from mucosal tissues in germ-free mice. However, they appear upon the 
colonization with select species of bacteria (39). Although many bacterial species present 
in the gut lack the riboflavin synthesis pathways. Therefore, there may be additional 
ligands yet to be identified.  
We never identified riboflavin metabolites in our mass spectrometric analysis of 
the E. coli sonicates, we cannot formally rule out their presence. Although we did find 
that riboflavin metabolites could stimulate MAIT cells, we were unable to find any in the 
fractions from E. coli that stimulated our hybridoma. There are several possible 
explanations considering the interaction between s-succinyldihydrolipoamide from E. 
coli identified by mass spectrometry and the riboflavin metabolites. Indeed, both 
riboflavin and the compound are important components of the TCA cycle. Both s-
succinyldihydrolipoamide and riboflavin synthesis pathways are conserved in the bacteria 
and yeast that stimulate MAIT cells and absent from those that do not stimulate MAIT 
cells. Alternatively, there may be several different types of antigens for MAIT cells and 
that variability in the MAIT TCR composition may allow for recognition of several 
classes of antigens. However, the data point to MAIT cell recognition of small, organic 
88 
compounds presented by MR1. Additional work will need to be completed to fully 
resolve the nature of the MAIT antigen and understand how the MAIT TCR is able to 
recognize it.  
 
Future studies on MAIT cell antigens 
 Given the recent discovery of MAIT cells and the pathogens to which they 
respond, there is certainly no shortage of areas to explore. The synthesis of the compound 
identified by mass spectrometry, s-succinyldihydrolipoamide, will be important for 
confirming it’s stimulatory ability. Crude synthesis of this compound has suggested that 
it has the potential to stimulate the MAIT hybridoma.  However, we will need to 
synthesize this compound in a more efficient process. Another way we plan to explore 
the stimulatory capability of this compound is to transduce non-stimulatory bacteria with 
the E. coli genes they lack (i.e. sucA, sucB, lpd). The addition of these components may 
use available 2-oxoglutarate as a substrate to produce succinyl-coA in a manner similar to 
E. coli. This may provide the s-succinyldihydrolipoamide to allow the non-stimulatory 
bacteria to stimulate the MAIT hybridoma.    
 Regarding the riboflavin metabolites, we are currently taking several approaches. 
First, we are in the process of separating out the riboflavin components by RP-HPLC. 
Fractions were collected, lyophilized, and used to stimulate the MAIT hybridoma. 
Stimulatory fractions were analyzed by mass spectrometry and we are in the process of 
identifying the metabolites present in each of the stimulatory fractions. Second, we are 
analyzing the purity of the 7-ethyl-8-chloro-10-(1'-D-ribityl) isoalloxazine mixture. We 
89 
are attempting to identify the presence of any additional metabolites that may stimulate 
the MAIT hybridoma.  
 In both cases, we need a way to definitively test whether or not the antigens are 
being presented by MR1 to the MAIT hybridoma. We plan to arrive at this answer 
through the use of soluble MR1 protein. Much like what has been done in regards to 
CD1d antigen presentation to NKT cells, we plan to load soluble MR1 protein with a 
specific antigen for presentation to the MAIT hybridoma. This will eliminate the 
requirement for an antigen-presenting cell and allow us to directly test whether or not the 
antigen is presented by MR1. It is our goal to chemically synthesize the compounds 
identified by mass spectrometry for antigenic activity in this assay.  
 Nevertheless, our data and the data of others point to MAIT TCR recognition of 
small molecules. These antigens are much smaller than peptides or most of the lipids 
defined as T cell antigens. This raises the intriguing notion that T cells have the ability to 
recognize small, organic molecules that are much different from classical and CD1-
restricted T cells.  
 
Classes of antigen recognition by αβ  T cells 
 As a whole, αβ T cells are classified according to their selecting molecule. CD4+ 
T cells are selected by and respond to MHCII molecules, while CD8+ T cells are selected 
by and respond to MHCI molecules. However, αβ T cells may also be categorized by the 











Figure 6-1: Three broad classes of ligands recognized by TCRs: peptides, lipids, and 
vitamin metabolites. Examples of each class of ligands are shown. Peptides from 
MCMV and flagellin are presented by MHC class I or class II to classical αβ T cells, 
respectively. Vitamin metabolites are presented to MAIT cells by MR1. The lipids, α-
galactosylceramide (αGalCer) and dideoxymycobactins presented to NKT cells and 
CD1a-restricted T cells, respectively. Reprinted from Young and Gapin. Mucosal 
associated invariant T cells: Don't forget your vitamins. (2012) pp. 1-4 with permission 





T cells are categorized as those that recognize peptide antigens. This category also 
includes H2-M3-restricted T cells, which respond to N-formylated peptide antigens 
derived from bacteria. CD1-restricted T cells, including NKT cells, can be grouped 
together due to their recognition of lipidic antigens. A third and new category of T cells, 
which is defined currently as MAIT cells, are postulated to recognize small metabolites 
presented by MR1. The existence of several classes of antigens available for recognition 
by T cells, the immune system is able to efficiently recognize and clear the breadth of 
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